EurekaMag PDF full texts Chapter 32,474

Katz, David H.; Habbema, L.; De Boulle, K.; Roders, G.A. 1994: N-Docosanol cream is an effective topical treatment of recurrent herpes labialis. Antiviral Research 23(Suppl 1): 75

Marcelletti, J.F.; Lusso, P.; Katz, D.H. 1996: N-Docosanol inhibits in vitro replication of HIV and other retroviruses. Aids Research and Human Retroviruses 12(1): 71-74

Thomas, T.H.; Rutherford, P.A.; Wilkinson, R. 1993: N-Ethyl maleimide inhibition of human erythrocyte sodium, lithium countertransport Relation to abnormal activity. Journal of Physiology (Cambridge) 459: 383P

Angelico, M.; Mangiameli, A.; Della Guardia, P.; Sofia, M.; Nistri, A.; Maina, M.; Baiocchi, L.; Blasi, A. 1993: N-Ethyltauroursodeoxycholic acid, an amidated bile salt analogue resistant to deconjugation Metabolism and bile secretory properties after duodenal infusion in the rat. Hepatology 18(4 Part 2): 178A

Fisher, C.H. 1995: N-Fatty acids Comparison of published densities and molar volumes. Journal of the American Oil Chemists' Society 72(6): 681-685

Yamaoka, K.; Yusuf, I.; Seyama, I. 1992: N-Feruloyltyramine blocks the cardiac inward rectifier potassium channel. Japanese Journal of Physiology 42(Suppl ): S268

Kimoto, M.; Tsuji, H.; Ogawa, T. 1993: N-G,N-G-dimethylarginine dimethylaminohydrolase in the nitric oxide-generating tissue and cell systems of rats. Amino Acids 5(3): 431-432

Yokomori, H.; Oda, M.; Kamegaya, Y.; Kazemoto, S.; Ogi, M.; Tsukada, N.; Akiba, Y.; Nakamura, M.; Muraoka, M.; Ishii, H. 1995: N-G-L monomethyl arginine enhances bile canalicular contractions in primary culture- involvement of intracytoplasmic free calcium ion and Ca++-ATPase activity. Gastroenterology 108(4 Suppl): A1204

Olken, N.M.; Marletta, M.A. 1993: N-G-Methyl-L-arginine is an alternate substrate and mechanism-based inhibitor of nitric oxide synthase. FASEB Journal 7(7): A1203

Paik, W.K.; Kim, S. 1993: N(G)-Methylarginines: Biosynthesis, biochemical function and metabolism. Amino Acids 4(3): 267-286

Watson, M.; Poth, M.; Francis, G. 1993: N-G-Monomethyl-L-arginine directly stimulates in vitro Leydig cell testosterone production. Pediatric Research 33(5 Suppl): S19

Watkins, R.; Cook, I.; Mcleod, R. 1993: N-G-Monomethyl-L-arginine does not inhibit depressor responses to acetylcholine in rats. FASEB Journal 7(3-4): A775

Piotrovskij, V.K.; Kállay, Z.; Horecký, J.; Trnovec, T.; Raberger, G.; Krejcy, K. 1994: NG-nitro-L-arginine is not involved in enterohepatic cycling in rats. Drug Metabolism and Disposition: the Biological Fate of Chemicals 22(2): 338-339

Weintraub, N.L.; Sprague, R.S.; Stephenson, A.H.; Joshi, S.N.; Branch, C.A.; Lonigro, A.J. 1993: N-G-Nitro-L-arginine reduces venous admixture in intact anesthetized dogs. FASEB Journal 7(3-4): A650

Mayers, I.; Johnson, D.; Hurst, T. 1995: N-G-methyl-L-arginine restores hypoxic pulmonary vasoconstriction following burns in anaesthetized rabbits. Clinical and Investigative Medicine 18(4 Suppl): B24

Nowicki, P. 1994: N-G-monomethyl-L-arginine alters the relationship between pressure and flow in gut from 3-, but not 35-day old swine. Pediatric Research 35(4 Part 2): 244A

Rutten, M.J.; Muller, P.J.; Jou, A.J.; Fowler, W.M.; Bartos, D.; Meshul, C.; Allen, C.; Sheppard, B.C.; Crass, R.A.; Deveney, C.W.; Trunkey, D.D. 1996: N-G-monomethyl-L-arginine modulates H pylori induced cytoskeletal changes in gastric mucous epithelial cells. Gastroenterology 110(4 Suppl): A246

Puscas, I. 1995: N-G-monomethyl-L-arginine powerfully activates carbonic anhydrase I , while sodium nitroprusside as a source of nitric oxide, completely inhibits enzyme activity. Gastroenterology 108(4 Suppl): A672

Stefanovic Racic, M.; Meyers, K.; Meschter, C.; Coffey, J.W.; Hoffman, R.A.; Evans, C.H. 1994: N-G-monomethyl-L-arginine suppresses the development of adjuvant arthritis in rats. Moncada, S, Feelisch, M, Busse, R, Higgs, E A Portland Press Proceedings; The biology of nitric oxide, Vol 4 Enzymology, biochemistry and immunology 417-420

Kilbourn, R.; Fonseca, G.; Ewer, M.; Price, K.; Jones, E.; Logothetis, C.; Griffith, O. 1994: N-G-monomethyl-L-arginine, an inhibitor of nitric oxide production, reverses interleukin-2-mediated hypotension in humans. Moncada, S, Feelisch, M, Busse, B, Higgs, E A Portland Press Proceedings; The biology of nitric oxide, Vol 3 Physiological and clinical aspects 454-458

Chaturvedi, R.; Hjortdal, V.; Stenbg, E.; Ravn, H.; White, P.; Pedersen, J.; Christensen, T.; Thompsen, A.B.; Sorensen, K.; Redington, A. 1997: N-G-monomethyl-l-arginine improves left ventricular systolic function late after cardiopulmonary bypass in neonatal pigs. Journal of the American College of Cardiology 29(2 Suppl A): 99A

Charriaut Marlangue, C.; Margaill, I.; Walsh, R.J.; Plotkine, M.; Ben Ari, Y. 1995: N-G-nitro L-arginine methylester reduces cortical infarct and necrotic damage but not apoptotic cell loss. Society for Neuroscience Abstracts 21(1-3): 998

Glaser, E.; Lacolley, P.; Challande, P.; Brisac, A.B.; Safar, M.; Laurent, S. 1993: N-G-nitro-L-arginine and carotid arterial pressure-diameter relationship in vivo in rats. Journal of Hypertension 11(Suppl 5): S427-S428

Yamanaka, A.; Ishikawa, T.; Goto, K. 1997: N-G-nitro-L-arginine and indomethacin resistant relaxation induced by acetylcholine in the guinea pig coronary artery. Japanese Journal of Pharmacology 73(Suppl 1): 199P

Valdovinos, M.A.; Meulemans, A.L.; De Ridder, W.J.E.; Van Bergen, P.J.E.; Schuurkes, J.A.J. 1993: N-G-nitro-L-arginine inhibits NANC relaxations and unmasks cholinergic contractions in the isolated lower esophageal sphincter of the pig. Gastroenterology 104(4 Suppl): A861

Kurantsin Mills, J.; Cassidy, M.M.; Stafford, R.E.; Wagner, T.; Weglicki, W.B. 1995: N-G-nitro-L-arginine methyl ester augments circulating inflammatory cells during magnesium-deficiency in the rat. FASEB Journal 9(4): A709

Lo, S.; Lot, T.Y.; Hind, R.; Wilson, V.G. 1995: N-G-nitro-L-arginine methyl ester can elicit endothelium-independent contractions in the porcine isolated coronary artery. British Journal of Pharmacology 116(Proceedings Suppl ): 188P

Rivas-Cabañero, L.; Valdivielso, J.M.; López-Novoa, J.M. 1996: NG-nitro-L-arginine methyl ester causes glomerular nitrite production in long-term incubations. Nephron 73(1): 97-98

Goldsmith, P.C.; Levell, N.J.; Foreman, J.C.; Dowd, P.M. 1994: N-G-nitro-L-arginine methyl ester is an inhibitor of cutaneous vasodilatation due to calcitonin gene-related peptide. Journal of Investigative Dermatology 102(4): 645

Hellyer, P.W.; Plummer, D.D.; Johnson, L.W.; Olson, N.C. 1995: N-G-nitro-L-arginine methyl ester potentiates endotoxin-induced cardiopulmonary dysfunction and release of eicosanoids in pigs. FASEB Journal 9(3): A131

Lamarca, S.; Carr, G.; Dunn, R.W. 1995: N-G-nitro-L-arginine methyl ester, N-G-nitro-L-arginine and 7-nitroindazole are anxiolytic in the Vogel lick-shock conflict paradigm following bolus intravenous administration. FASEB Journal 9(4): A922

Medhrust, A.D.; Parson, A.A.; Kay, S.L.; Murkitt, K.L.; Smith, S.J.; Hunter, A.J. 1994: N-G-nitro-L-arginine p-nitroanilide inhibits neurogenic and endothelium-dependent relaxation in peripheral tissues. Moncada, S, Feelisch, M, Busse, B, Higgs, E A Portland Press Proceedings; The biology of nitric oxide, Vol 3 Physiological and clinical aspects 430-434

Piotrovskij, V.K.; Kállay, Z.; Krejcy, K.; Horecký, J.; Trnovec, T.; Raberger, G. 1993: NG-nitro-L-arginine pharmacokinetics in rats after a single intravascular and oral dose: an appearance of secondary concentration time peaks. Drug Metabolism and Disposition: the Biological Fate of Chemicals 21(5): 962-964

Yamamoto, R.; Niina, H.; Asada, Y.; Sumiyoshi, A.; Takasaki, K.; Wada, A. 1993: N-G-nitro-L-arginine suppresses noradrenaline overflow in rat isolated perfused mesenteric vasculature. Japanese Journal of Pharmacology 61(Suppl 1): 117P

Huskey, S.E.; Magdalou, J.; Ouzzine, M.; Siest, G.; Chiu, S.H. 1994: N-glucuronidation reactions. III. Regioselectivity of N-glucuronidation of methylbiphenyl tetrazole, methylbiphenyl triazole, and methylbiphenyl imidazole using human and rat recombinant UDP-glucuronosyltransferases stably expressed in V79 cells. Drug Metabolism and Disposition: the Biological Fate of Chemicals 22(4): 659-662

Eichele, A.; Boldt, W.; Knau, B.; Nicke, A.; Mutschler, E.; Markwardt, F.; Schmalzing, G. 1998: N-Glycan scanning and epitope insertion confirms predicted membrane topology of P2X3 receptors. Naunyn-Schmiedeberg's Archives of Pharmacology 357(4): R32

Kimura, S.; Toyoshima, K.; Cheng, J.; Oda, K.; Saku, T. 1998: N-Glycosylation of perlecan core protein in salivary adenoid cystic carcinoma cells. Molecular Biology of the Cell 9(Suppl ): 57A

Korsmeyer, K.K.; Guan, S.; Yang, Z.C.; Falick, A.M.; Ziegler, D.M.; Cashman, J.R. 1998: N-Glycosylation of pig flavin-containing monooxygenase form 1: determination of the site of protein modification by mass spectrometry. Chemical Research in Toxicology 11(10): 1145-1153

Rice, P.J. 1995: N-Heptanol reverses postsynaptic denervation supersensitivity in the rat vas deferens. FASEB Journal 9(3): A109

Nair, H.K. 1997: N-Het-substituted glycerophosphoethanolamines. Official Gazette of the United States Patent and Trademark Office Patents 1205(5): 3900

Norcini, G.; Santangelo, F. 1995: N-Heteroaryl substituted derivatives of propanamide useful in the treatment of cardiovascular diseases. Official Gazette of the United States Patent and Trademark Office Patents 1177(1): 337

Nagamine, M.; Yamamoto, K.; Matsui, Y.; Horiuchi, K.; Yoshida, M. 1995: N-Heteroaryl--phenylurea derivatives, their production and use. Official Gazette of the United States Patent and Trademark Office Patents 1180(1): 362

Takeuchi, Y. 1993: N-hexane polyneuropathy in Japan: a review of n-hexane poisoning and its preventive measures. Environmental Research 62(1): 76-80

Collis, C.S.; Rice Evans, C.; Davies, M.J. 1993: N-Hexano-N-methyl-hydroxamate, a novel drug, attenuates reperfusion-induced contracture in the isolated perfused rat heart. Journal of Physiology (Cambridge) 459: 359P

Gouverneur, V.; Lalloz, M.N. 1996: N-Hydroxy-alpha-amino phosphonate derivatives as potential haptens for eliciting catalytic antibodies. Tetrahedron Letters 37(35): 6331-6334

Mano, T.; Stevens, R.W.; Nakane, M. 1995: N-Hydroxyurea derivatives as antiallergy and antiinflammatory agents. Official Gazette of the United States Patent and Trademark Office Patents 1180(1): 358

Costales, M.J.; Ehr, R.J.; Kleschick, W.A.; Van, H., J.C.; Reifschneider, W. 1995: N-Indazolyl1,2,4triazolo1,5-Cpyrimidine-2-sulfonamide herbicides. Official Gazette of the United States Patent and Trademark Office Patents 1178(1): 331-332

Ma, Z.Q.; Santagati, S.; Pollio, G.; Cattaneo, E.; Maggi, A. 1993: N-MYC and c-fos mRNA levels in estrogen activated neuroblastoma cells. Society for Neuroscience Abstracts 19(1-3): 881

Sivak, L.F.; Dillon, P.A.; Johnston, J.M.; Brodeur, G.M.; Carroll, W.L. 1993: N-MYC promoter activity in human neuroblastoma. Pediatric Research 33(4 Part 2): 148A

Barb, C.R.; Barrett, J.B.; Rampacek, G.B.; Kraeling, R.R. 1992: N-Methyl-D,L-aspartate modulates luteinizing hormone but not growth hormone secretion from pig pituitary cells. Society for Neuroscience Abstracts 18(1-2): 444

Hallak, M.; Hotra, J.W. 1997: N-Methyl-D-Aspartate receptor binding in the rat brain Effect of pregnancy stage. American Journal of Obstetrics and Gynecology 176(1 Part 2): S101

Evans, P.D.; Reale, V.; Merzon, R.M.; Villegas, J. 1992: N-Methyl-D-aspartate and non-NMDA type glutamate receptors modulate the membrane potential of the Schwann cell of the squid giant nerve fibre. Journal of Experimental Biology 173: 229-249

Verma, A.; Kulkarni, S.K. 1995: N-Methyl-D-aspartate receptor participation in Parkinson's disease, a neurodegenerative disorder. Annals of the new York Academy of Sciences 765: 327

D.L.renzo, R.J.; Sombati, S. 1996: N-Methyl-D-aspartate receptor-dependent induction of epileptogenesis in an in vitro hippocampal model of epilepsy. Neurology 46(2 Suppl): A357

Marini, A.M.; Damschroder Williams, P.; Paul, S.M. 1993: N-Methyl-D-aspartate receptor-mediated neuroprotection in cerebellar granule cells requires new RNA and protein synthesis. Amino Acids 5(3): 445

Bockaert, J.; Olivier, M.; Manzoni, O.; Lafon Cazal, M.; Marin, P.; Fagni, L. 1993: N-Methyl-D-aspartate receptors and nitric oxide. Journal of Neurochemistry 61(Suppl ): S52

Cumberbatch, M.J.; Headley, P.M. 1993: N-Methyl-D-aspartate receptors and spinal nociceptive processing. Society for Neuroscience Abstracts 19(1-3): 1782

Mahachoklertwattana, P.; Sanchez, J.; Grumbach, M.M.; Kaplan, S.L.; Rosenthal, S.M. 1993: N-Methyl-D-aspartate stimulates LHRH release via the NMDA receptor in an LHRH neuronal cell line. Pediatric Research 33(5 Suppl): S34

Morari, M.; O'connor, W.T.; Ungerstadt, U.; Fuxe, K. 1992: N-Methyl-D-aspartic acid differentially regulates dopamine, GABA and glutamate release in the dorsolateral striatum of the halothane anesthetized rat An in vivo microdialysis study. Society for Neuroscience Abstracts 18(1-2): 916

Yates, S.; Marnocha, P.; Huston, K.; Deutsch, S.; Spriggs, D. 1993: N-Methyl-L-arginine does not reduce cytotoxicity or alter gene expression in cells treated with tumor necrosis factor. Proceedings of the American Association for Cancer Research Annual Meeting 34: 443

Estienne, M.J.; Harter Dennis, J.M.; Barb, C.R.; Hartsock, T.G.; Campbell, R.M.; Armstrong, J.D. 1994: N-Methyl-d,l-aspartate -induced growth hormone secretion in barrows Mechanism of action. Journal of Dairy Science 77(Suppl 1): 287

Petronis, A.; O'hara, K.; Barr, C.L.; Kennedy, J.L.; Van Tol, H.H.M. 1994: N-Mononucleotide polymorphism in the human D4 dopamine receptor gene. Human Genetics 93(6): 719

Yan, X.; Chua, M.-S.; Sun, H.; So, S. 2008: N-Myc down-regulated gene 1 mediates proliferation, invasion, and apoptosis of hepatocellular carcinoma cells. Cancer Letters 262(1): 133-142

Chu, J.J.; Xu, Y.C.; Ye, B.F. 1994: N-nitroso-compounds of pickles in the areas with high incidence of digestive cancers and their mutagenic effects. Zhonghua Yu Fang Yi Xue Za Zhi 28(4): 202-205

Schleicher, R.L.; Fallon, M.T.; Austin, G.E.; Zheng, M.; Zhang, M.; Collins, D.C. 1993: N-Nitroso-N-methylurea induction of prostate cancer in rats. Proceedings of the American Association for Cancer Research Annual Meeting 34: 249

Xiang, Y.ejun; Chen, Jie; Schinazi, Raymond, F.; Zhao, Kang 1995: N-O diheterocyclic nucleosides Synthesis of 2-N-methyl-3-hydroxymethyl-1,2-isoxazolidinylthymidine. Tetrahedron Letters 36(40): 7193-7196

Crespo,G.; Rodriguez,I.; Martinez,O. 2008: N-P-K balance in a milk production system on a C nlemfuensis grassland and a biomass bank of P purpureum CT-115 clone. Multifunctional Grasslands In A Changing World, Volume 1: Xxi International Grassland Congress And Viii International Rangeland Congress, Hohhot, China, 29 E 5 Y: 4

Harrold, J.A.; Elliott, J.E.; Elliott, A.A. 1995: N-Pentanol block of rat brain RCK1 potassium channels expressed in Xenopus oocytes Comparison with block by external tetraethylammonium ions. Journal of Physiology (Cambridge) 489P: 59P

Harrold, J.A.; Elliott, J.R.; Elliott, A.A. 1996: N-Pentanol causes depolarizing shifts in the voltage dependence of both activation and inactivation of rat brain RCK4 fast-inactivating potassium channels expressed in Xenopus oocytes. Journal of Physiology (Cambridge) 491P: 89P

Arasappan, A.; Fraser Reid, B. 1995: N-Pentenyl furanosides Synthesis and glycosidation reactions of some galacto derivatives. Tetrahedron Letters 36(44): 7967-7970

Merritt, J.R.; Fraser Reid, B. 1992: N-Pentenylglycoside methodology for rapid assembly of homoglycans exemplified with the nonasaccharide component of a high-mannose glycoprotein. Journal of the American Chemical Society 114(21): 8334-8338

Matesic, L.; Locke, J.M.; Bremner, J.B.; Pyne, S.G.; Skropeta, D.; Ranson, M.; Vine, K.L. 2008: N-phenethyl and N-naphthylmethyl isatins and analogues as in vitro cytotoxic agents. Bioorganic and Medicinal Chemistry 16(6): 3118-3124

Kuo, E.A. 1995: N-Phenyl-2-cyano-3-hydroxy-propenamides. Official Gazette of the United States Patent and Trademark Office Patents 1174(3): 1925

Bourzat, J.D.; Capet, M.; Cotrel, C.; Guyon, C.; Manfre, F.; Roussel, G. 1994: N-Phenyl-N-alkoxycarbonylalkyl glycinamides, their preparation and the medicaments containing them. Official Gazette of the United States Patent and Trademark Office Patents 1169(3): 1738

Dostert, P.; Pevarello, P.; Heidempergher, F.; Varasi, M.; Bonsignori, A.; Roncucci, R. 1995: N-Phenylalkyl substituted alpha-amino carboxamide derivatives and process for their preparation. Official Gazette of the United States Patent and Trademark Office Patents 1171(3): 1804

Blough, H.A.; Soike, K.; Shannon, W.; Wyde, P.; Pavan Langston, E.D.nkel And, D. 1993: N-Phosphonoacetylaspartate An effective and safe broad spectrum antiviral. Antiviral Research 20(Suppl 1): 175

Bettarini, F.; Meazza, G.; La, P., P.; Zanardi, G.; Massimini, S.; Reggiori, F. 1996: N-Polyhalobenzyl-pyrazole carboxamides endowed with acaricidal and insecticidal activity. Official Gazette of the United States Patent and Trademark Office Patents 1188(5): 3723

Sterling, J.; Veinberg, A.; Lerner, D.; Goldenberg, W.; Levy, R.; Youdim, M.; Finberg, J. 1998: N-Propargyl-1-aminoindan and derivatives Highly selective and potent inhibitors of monoamine oxidase B. Journal of Neural Transmission Suppl 52: 301-305

Kimura, M.; Takabuchi, S.; Tanaka, T.; Murata, M.; Nishi, K.; Oda, S.; Oda, T.; Kanai, M.; Fukuda, K.; Kizaka-Kondoh, S.; Adachi, T.; Takabayashi, A.; Semenza, G.L.; Hirota, K. 2008: N-Propyl gallate activates hypoxia-inducible factor 1 by modulating intracellular oxygen-sensing systems. Biochemical Journal 411(1): 97-105

Cillo, C.; Cantile, M.; Mortarini, R.; Tiberio, C.; Barba, P.; Anichini, A.; Poupon, M.F. 1995: N-RAS mutation and p53 expression correlate to HOX gene expression in clonal melanoma populations isolated from a single human melanoma metastasis. Proceedings of the American Association for Cancer Research Annual Meeting 36: 564

Wang, J.C.; Wong, P.M.C.; Chung, S.W. 1993: N-Ras oncogene mutation in agnogenic myeloid metaplasia. Blood 82(10 Suppl 1): 557A

Mor, A.; Keren, G.; Kloog, Y.; George, J. 2008: N-Ras or K-Ras inhibition increases the number and enhances the function of Foxp3 regulatory T cells. European Journal of Immunology 38(6): 1493-1502

Grant, P.; Veeranna; Takashashi, M.; Pant, H.C. 1995: N-SEC1/P67, a syntaxin binding proteins, is also a regulator of CDK5 in a multimeric complex bound to the neuronal cytoskeleton. Molecular Biology of the Cell 6(Suppl ): 376A

Peck, J.V.; Wysocki, R.J.; Uwaydah, I.M.; Cusack, N.J. 1997: N-Substituted 9-alkyladenines. Official Gazette of the United States Patent and Trademark Office Patents 1202(4): 3106

Steiner, G.; Unger, L.; Behl, B.; Teschendorf, H J. 1996: N-Substituted azabicyclo320heptane derivatives as neuroleptics, the preparation and use thereof. Official Gazette of the United States Patent and Trademark Office Patents 1186(4): 2817-2818

Buzzetti, F.; Crugnola, A.; Longo, A.; Brasca, M.G.; Ballinari, D. 1997: N-Substituted beta-aryl- and beta-heteroaryl-alpha-cyanoacrylamide derivatives and process for their preparation. Official Gazette of the United States Patent and Trademark Office Patents 1200(5): 3556

Albaugh, P.; White, G.J.; Garst, M.E. 1995: N-Substituted derivatives of 3R,4R-ethyl- methyl-2-pyrrolidone. Official Gazette of the United States Patent and Trademark Office Patents 1178(4): 2396

Thogersen, H.; Hansen, B.S.; Peschke, B.; Hansen, T.K.; Andersen, K.E. 1998: N-Substituted naphthofused lactams. Official Gazette of the United States Patent and Trademark Office Patents 1215(1): 585-586

Ohnishi, M.; Tajima, S.; Nishiguchi, T.; Tsubata, K. 1998: N-Substituted phenylcarbamic acid derivatives, a process for production thereof, agricultural and horticultural fungicides, intermediates of the derivatives and a process for production thereof. Official Gazette of the United States Patent and Trademark Office Patents 1206(4): 3001

Porter, J.R.; Morphy, J.R.; Millican, T.A.; Beeley, N.R.A. 1996: N-Sulphonylamino derivatives of dipetide compounds as metalloproteinase inhibitors. Official Gazette of the United States Patent and Trademark Office Patents 1187(4): 2883

Buckley, M.G.; Markandu, N.D.; Sagnella, G.A.; Macgregor, G.A. 1994: N-Terminal atrial natriuretic peptide and atrial natriuretic peptide in human plasma Investigation of plasma levels and molecular circulating form using radioimmunoassays for pro-atrial natriuretic peptide , pro-atrial natriuretic peptide and atrial natriuretic peptide. Clinical Science 87(3): 311-317

Yoshitomi, S.; Kurokawa, T.; Igarashi, K. 1996: N-Terminally truncated HST-1 is a platelet-increasing factor. Official Gazette of the United States Patent and Trademark Office Patents 1190(4): 2890

Haviv, F.; Fitzpatrick, T.D.; Swenson, R.E.; Nichols, C.J.; Mort, N.A. 1996: N-Terminus modified analogs of LHRH. Official Gazette of the United States Patent and Trademark Office Patents 1184(4): 2336-2337

Wegner, A.M.; Nebhan, C.A.; Hu, L.; Majumdar, D.; Meier, K.M.; Weaver, A.M.; Webb, D.J. 2008: N-wasp and the arp2/3 complex are critical regulators of actin in the development of dendritic spines and synapses. Journal of Biological Chemistry 283(23): 15912-15920

Sharma, A.K. 1996: N-acetonyl-substituted-amides. Official Gazette of the United States Patent and Trademark Office Patents 1187(4): 2824

Thayer, J.M.; Mirkes, P.E. 1994: N-acetoxy-2-acetylaminofluorene-induced apoptosis. Teratology 49(5): 383

Clark, J.B. 1998: N-acetyl aspartate: a marker for neuronal loss or mitochondrial dysfunction. Developmental Neuroscience 20(4-5): 271-276

Ebisu, T.; Rooney, W.D.; Graham, S.H.; Weiner, M.W.; Maudsley, A.A. 1993: N-acetyl aspartate as a marker of neuronal viability in kainate-induced epilepsy studied by magnetic resonance spectroscopic imaging. Society for Neuroscience Abstracts 19(1-3): 604

Ueda, H.; Matsumoto, M.; Nakano, M.; Li, J.Y.; Yoshida, Y.; Yanagihara, T. 1995: N-acetyl aspartate levels in delayed neuronal death in the hippocampus of the gerbil brain. Journal of Neurochemistry 64(Suppl 1): S13

Leshinsky, E.; Ribeiro, L.; Gage, D.A.; Kolodny, E.H. 1997: N-acetyl aspartoglutamate metabolism in brain Application to Canavan disease. Journal of Neurochemistry 69(Suppl ): S192

Yamada, M.; Kojima, N.; Paranjpe, A.; Att, W.; Aita, H.; Jewett, A.; Ogawa, T. 2008: N-acetyl cysteine (NAC)-assisted detoxification of PMMA resin. Journal of Dental Research 87(4): 372-377

Berk, M.; Copolov, D.; Dean, O.; Lu, K.; Jeavons, S.; Schapkaitz, I.; Anderson-Hunt, M.; Judd, F.; Katz, F.; Katz, P.; Ording-Jespersen, S.; Little, J.; Conus, P.; Cuenod, M.; Do, K.Q.; Bush, A.I. 2008: N-acetyl cysteine as a glutathione precursor for schizophrenia--a double-blind, randomized, placebo-controlled trial. Biological Psychiatry 64(5): 361-368

Geudens, N.; Wuyts, W.A.; Rega, F.R.; Vanaudenaerde, B.M.; Neyrinck, A.P.; Verleden, G.M.; Lerut, T.E.; Van Raemdonck, D.E.M. 2008: N-acetyl cysteine attenuates the inflammatory response in warm ischemic pig lungs. Journal of Surgical Research 146(2): 177-183

Berk, M.; Copolov, D.L.; Dean, O.; Lu, K.; Jeavons, S.; Schapkaitz, I.; Anderson-Hunt, M.; Bush, A.I. 2008: N-acetyl cysteine for depressive symptoms in bipolar disorder--a double-blind randomized placebo-controlled trial. Biological Psychiatry 64(6): 468-475

Janssens, A.R.; Schurewegh, Al; De Clerck, L.S.; Bridts, C.H.; De Backer, W.A.; Stevens, W.J. 1998: N-acetyl cysteine induced changes in oxygen radical production and glutathion levels in neutrophils of patients with chronic obstructive pulmonary diseases. Journal of Allergy and Clinical Immunology 101(1 Part 2): S114

Pahan, K.; Skeikh, F.G.; Namboodiri, A.M.S.; Singh, I. 1997: N-acetyl cysteine inhibits induction of NO production by endotoxin or cytokine stimulated rat peritoneal macrophages, astrocytes and C6 glial cells. Journal of Neurochemistry 69(Suppl ): S187

Parry, W.; Poovala, V.; Kanji, V.; Salahudeen, A. 1997: N-acetyl cysteine prevents cisplatin -nephrotoxicity in-vitro and in-vivo Role of glutathione. Journal of Investigative Medicine 45(1): 70A

Vasdev, S.; Wadhawan, S.; Ford, C.A.; Gadag, V. 1997: N-acetyl cysteine prevents fructose induced hypertension. Clinical Chemistry 43(6 Part 2): S193

Paranjpe, A.; Sung, E.C.; Cacalano, N.A.; Hume, W.R.; Jewett, A. 2008: N-acetyl cysteine protects pulp cells from resin toxins in vivo. Journal of Dental Research 87(6): 537-541

Parry, W.; Poovala, V.; Kanji, V.; Salahudeen, A. 1996: N-acetyl cysteine protects the kidney against cisplatin -toxicity in vitro and in vivo. Journal of the American Society of Nephrology 7(9): 1844

Morrissey, J.; Duan, L.; Klahr, S. 1996: N-acetyl cysteine treatment alters nuclear transcription factor activity and monocyte infiltration of the kidney during ureteral obstruction. Journal of the American Society of Nephrology 7(9): 1830

Hofbauer, J.; Fang Kircher, S.; Wiener, H.; Susani, M.; Steiner, G.; Marberger, M. 1995: N-acetyl neuraminic acids Key substances in renal calculogenesis?. Journal of Urology 153(4 Suppl): 350A

Kuratko, C.; Brinlee, R.; Pence, B. 1997: N-acetyl transferase activity is decreased in rats fed high fat diets containing menhaden oil. FASEB Journal 11(3): A578

Hanaya, R.; Kiura, Y.; Kurisu, K.; Sakai, N.; Serikawa, T.; Sasa, M. 2008: N-acetyl-L-aspartate activates hippocampal CA3 neurons in rodent slice preparations. Brain Research Bulletin 75(5): 663-667

Molony, D.A.; Patel, A.; Mehta, P. 1997: N-acetyl-L-cysteine abolishes apoptosis of ST-1 cells induced by nephrotoxicant pesticides. Journal of the American Society of Nephrology 9(Program and Abstr. Issue): 606A

Dorward, A.; Singh, G. 1996: N-acetyl-L-cysteine alters cell cycle progression in ovarian cancer cells of epithelial origin. FASEB Journal 10(6): A1288

Guijarro,L.G.; Mate,J.; Gisbert,J.P.; Perez-Calle,J.L.; Marin-Jimenez,I.; Arriaza,E.; Olleros,T.; Delgado,M.; Castillejo,M.S.; Prieto-Merino,D.; GonzalezLara,V.; Pena,A.S. 2008: N-acetyl-L-cysteine combined with mesalamine in the treatment of ulcerative colitis randomized, placebo-controlled pilot study. World Journal Of Gastroenterology: 18, 2851-2857

Torii, Y.; Saito, H.; Matsuki, N. 1994: N-acetyl-L-cysteine prevented release of 5-hydroxytryptamine from suncus small intestine induced by cisplatin. Japanese Journal of Pharmacology 64(Suppl 1): 285P

Yan, C.Y.I.; Ferrari, G.; Joyce, M.P.; Greene, L.A. 1994: N-acetyl-L-cysteine prevents apoptotic death of trophic-factor-deprived PC12 cells and sympathetic neurons. Society for Neuroscience Abstracts 20(1-2): 681

Thielemann, L.E.; Rosenblut, G. 1995: N-acetyl-L-cysteine prevents the increase in papillary DNA synthesis triggered by bromoethylamine-induced necrosis. Medical Science Research 23(6): 399-400

Oeda, T.; Henkel, R.; Nagai, A.; Schill, W.B.; Ohmori, H. 1997: N-acetyl-L-cysteine scavenges reactive oxygen species in human semen. International Journal of Andrology 20(Suppl 1): 16

Smith, C.V.; Blomkalns, A.L.; Rogers, L.K.; Tamura, T.; Tonoki, H.; Hansen, T.N. 1995: N-acetyl-P-benzoquinone imine toxicity in Chinese hamster ovary cells with genetically modified glutathione reductase activities. FASEB Journal 9(4): A694

Lu, X.C.M.; Tang, Z.; Liu, W.; Lin, Q.; Slusher, B.S. 1998: N-acetyl-aspartyl-glutamate protects against focal cerebral ischemia in a rat model of MCAO. Society for Neuroscience Abstracts 24(1-2): 581

Miadonna, A.; Milazzo, N.; Cottini, M.; Tedeschi, A. 1994: N-acetyl-aspartyl-glutamic acid inhibits very late antigen-induced nasal neutrophilia and eosinophilia. Journal of Allergy and Clinical Immunology 93(1 Part 2): 272

Stojcheva Taneva, O.; Ivanovski, N.; Grozdanovski, R.; Polenakovic, M. 1995: N-acetyl-beta-D-glucosaminidase and B-2 microglobulin in diabetics in relation to microangiopathy. Journal of the American Society of Nephrology 6(3): 456

Stojanov, M.; Mehanovic Hanjalic, J.; Sanicanin, Z. 1994: N-acetyl-beta-D-glucosaminidase and glutathione-S-transferase as indicators of cisplatin nephrotoxicity. Clinical Chemistry 40(6): 1125

Tomasiak, M.M.; Tomasiak, M.; Zietkowski, Z.; Skiepko, R.; Bodzenta-Lukaszyk, A. 2008: N-acetyl-beta-hexosaminidase activity in asthma. International Archives of Allergy and Immunology 146(2): 133-137

Robinson, K.A.; Hensley, K.; Stewart, C.A.; Pye, Q.; Grammas, P.; Floyd, R.A. 1998: N-acetyl-cysteine and phenyl-tert-butyl nitrone prevent IL-1beta, H2O2, and hyperosmotic activation of p38 and their inactivation of phosphatases in primary rat glial cells. Society for Neuroscience Abstracts 24(1-2): 864

De Vries, N.; De Flora, S. 1993: N-acetyl-l-cysteine. Journal of Cellular Biochemistry. Supplement 17f: 270-277

Lindner, H.A.; Täfler-Naumann, M.; Röhm, K.-H. 2008: N-acetylamino acid utilization by kidney aminoacylase-1. Biochimie 90(5): 773-780

Miller, S.L.; Daikhin, Y.; Yudkoff, M.; Duncan, I. 1997: N-acetylaspartate Levels in brain regions during development and implications regarding its cellular specificity. Journal of Neurochemistry 69(Suppl ): S175

Mehta, V.; Razavi, P.; Tamjidi, P.; Datwani, A.; Scharaf, R.; Wroblewska, B.; Namboodiri, M.A.A. 1995: N-acetylaspartate as an acetyl source for lipid synthesis in cultured astrocytes from 8 day old rats. Society for Neuroscience Abstracts 21(1-3): 564

Tsai, G.; Coyle, J.T. 1995: N-acetylaspartate in neuropsychiatric disorders. Progress in Neurobiology 46(5): 531-540

Wroblewska, B.; Surin, A.; Pshenichkin, S.; Wroblewski, J.T.; Neale, J.H. 1996: N-acetylaspartylglutamate as a selective agonist of mGluR3. Neuropharmacology 35(6): A34

Yourick, D.L.; Koenig, M.L.; Long, J.B. 1998: N-acetylaspartylglutamate attenuates hypoxia- and NMDA-induced cell death in spinal cord cultures. Society for Neuroscience Abstracts 24(1-2): 463

Burlina, A.B.; Ferrari, V.; Dionisi Vici, C.; Zacchello, F.; Burlina, A.P. 1994: N-acetylaspartylglutamate in urine and CSF in Canavan Disease. Pediatric Research 35(4 Part 2): 379A

Neale, J.H.; Wroblewska, B. 1993: N-acetylaspartylglutamate inhibits cyclic GMP formation in cerebellar granule cells. Society for Neuroscience Abstracts 19(1-3): 1135

Long, J.B.; Yourick, D.L.; Meyerhoff, J.L. 1998: N-acetylaspartylglutamate protects against dynorphin A-induced ischemic spinal cord injury in rats. Society for Neuroscience Abstracts 24(1-2): 463

Burlina, A.P.; Skaper, S.D.; Mazza, M.R.; Ferrari, V.; Lcon, A.; Burlina, A.B. 1994: N-acetylaspartylglutamate selectively inhibits neuronal responses to N-methyl-D-aspartate. Society for Neuroscience Abstracts 20(1-2): 247

Fuhrman, S.; Neale, J.H. 1993: N-acetylaspartylglutamate studied in medial prefrontal cortex in rats using in vivo microdialysis. Society for Neuroscience Abstracts 19(1-3): 920

Passani, L.A.; Vonsattel, J.P.G.; Carter, R.E.; Coyle, J.T. 1996: N-acetylaspartylglutamate, N-acetylaspartate and N-acetylated alpha-linked acidic dipeptidase in human brain and their alterations in Huntingtons and Alzheimers disease. Society for Neuroscience Abstracts 22(1-3): 204

Jang, I.J.; Shin, S.G.; Yim, D.S.; Woo, J.I.; Lee, S.W.; Kim, S.H. 1993: N-acetylation and oxidation capacities in Korean patients with bladder cancer. Clinical Pharmacology and Therapeutics 53(2): 158

Wong, K.P.; Sit, K.H.; Lim, B.G. 1992: N-acetylation in human liver and human cells in culture. Acta Cytologica 36(5): 845

Muimo, R.; Isaac, R.E. 1993: N-acetylation of 5-HT is a major metabolic pathway in nematodes and is developmentally regulated in Caenorhabditis elegans. Journal of Cellular Biochemistry Suppl 1993(17 Part C): 117

Maehler, S.; Schlattjan, J.H.; Foellmann, W.; Degen, G.H. 1996: N-acetylation of benzidine in cultured porcine urinary bladder epithelial cells and ovine seminal vesicle cells. Naunyn-Schmiedeberg's Archives of Pharmacology 353(4): R112

Asada, M.; Goto, H.; Abe, M.; Tachibana, T.; Suzuki, Y.; Suzuki, T. 1997: N-acetylation polymorphism in Japanese patients with sarcoidosis. Pharmacogenetics 7(4): 341-344

Martell, K.J.; Weber, W.W. 1993: N-acetylation polymorphism in liver and pancreas of inbred rats. Drug Metabolism and Disposition: the Biological Fate of Chemicals 21(5): 965-966

Kaku, H.; Shibuya, N.; Xu, P.; Aryan, A.P.; Fincher, G.B. 1997: N-acetylchitooligosaccharides elicit expression of a single -beta-glucanase gene in suspension-cultured cells from barley. Physiologia Plantarum 100(1): 111-118

Kuchitsu, K.; Shibuya, N. 1994: N-acetylchitooligosaccharides, specific fungal elicitor for defense responses, induce transient generation of active oxygen species in suspension-cultured rice cells. Asada, K, Yoshikawa, T International Congress Series; Frontiers of reactive oxygen species in biology and medicine 255-256

Moldéus, P.; Cotgreave, I.A. 1994: N-acetylcysteine. Methods in Enzymology 234: 482-492

Cotgreave, I.A. 1997: N-acetylcysteine: pharmacological considerations and experimental and clinical applications. Advances in Pharmacology 38: 205-227

Rigberg, D.A.; Blinman, T.A.; Lane, J.S.; Kim, F.S.; Hines, O.J.; Mcfadden, D.W.; Chandler, C.F. 1998: N-acetylcysteine abrogates the systemic response to murine intestinal ischemia/reperfusion. Gastroenterology 114(4 Part 2): A1420

Poptic, E.J.; Chai, Y.C.; Faruqi, R.; Chisolm, G.M.; Dicorleto, P.E. 1994: N-acetylcysteine alters glutathione levels and redox state in human umbilical vein endothelial cells Effect on NF-kappa-B binding activity. Molecular Biology of the Cell 5(Suppl ): 372A

Cortelezzi, A.; Sarina, B.; Cattaneo, C.; Cristiani, S.; Silvestris, I.; Motta, M.; Ibatici, A.; Maiolo, A.T. 1998: N-acetylcysteine and all-trans retinoic acid on hemopoiesis in myelodysplastic syndromes Effect on apoptosis and clonogenic potential. Blood 92(10 Suppl 1 Part 1-2): 631A

Nakano, H.; Nagasaki, H.; Yoshida, K.; Kigawa, G.; Fujiwara, Y.; Kitamura, N.; Kuzume, M.; Takeuchi, S.; Sasaki, J.; Shimura, H.; Yamaguchi, M.; Kumada, K. 1998: N-acetylcysteine and anti-ICAM-1 monoclonal antibody reduce ischemia-reperfusion injury of the steatotic rat liver. Transplantation Proceedings 30(7): 3763

Betts, W.H.; Zhang, Y.; Rokicinski, M.; Horowitz, J.D. 1993: N-acetylcysteine and captopril inhibit but S-nitroso-N-acetylcysteine stimulates human neutrophil free radical production. Circulation 88(4 Part 2): I90

Vivot, C.; Stump, D.D.; Schwartz, M.E.; Theise, N.D.; Miller, C.M. 1993: N-acetylcysteine attenuates cold ischemia/reperfusion injury in the isolated perfused rat liver. Transplantation Proceedings 25(2): 1983-1984

Sen, C.K.; Rankinen, T.; Vaisanen, S.; Rauramaa, R. 1994: N-acetylcysteine attenuates exercise associated blood glutathione oxidation. Medicine and Science in Sports and Exercise 26(5 Suppl): S132

Demols, A.; Van Laethem, J.L.; Quertinmont, E.; Louis, H.; Le Moine, O.; Deviere, J. 1998: N-acetylcysteine decreases chemo- and cytokine release and pancreatitis severity in mice. Digestion 59(3): 230

Koide, Y.ji; Dalle Lucca, Jurandir; Scicli, A.G.illermo 1996: N-acetylcysteine decreases neointima formation after balloon injury of the rat carotid artery. Circulation 94(8): I403-I404

Vosters, O.; Beuneu, C.; Goldman, M.; Verhasselt, V.ér. 2008: N-acetylcysteine derivative inhibits CD40-dependent proinflammatory properties of human pancreatic duct cells. Pancreas 36(4): 363-368

Brisseau, G.F.; Marshall, J.C.; Cheung, P.Y.C.; Rotstein, O.D. 1993: N-acetylcysteine differentially modulates macrophage activation by lipopolysaccharides. Surgical Forum 44: 16-18

Pirazzi, B.; Gonzalez, P.; Avakian, E.; Fitzovich, D.; Collazo, V.; Mass, H. 1995: N-acetylcysteine diminishes vascular injury produced by carotid artery angioplasty in rabbits. FASEB Journal 9(3): A343

Haase, M.; Haase-Fielitz, A.; Ratnaike, S.; Reade, M.C.; Bagshaw, S.M.; Morgera, S.; Dragun, D.; Bellomo, R. 2008: N-Acetylcysteine does not artifactually lower plasma creatinine concentration. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 23(5): 1581-1587

Johnson, D.; Simone, C.; Derewlany, L.O.; Byrne, B.; Koren, G. 1995: N-acetylcysteine does not cross the human term placenta. FASEB Journal 9(4): A693

Khawli, F.A.; Stokic, D.S.; Koch, S.M.; Leis, A.A.; Reid, M.B. 1994: N-acetylcysteine does not inhibit high-frequency muscle fatigue in humans. FASEB Journal 8(4-5): A57

Vercelino, R.; Tieppo, J.; Dias, A.S.õe.; Marroni, C.áu.A.; Garcia, E.; Meurer, L.; Picada, J.N.; Marroni, N.P. 2008: N-acetylcysteine effects on genotoxic and oxidative stress parameters in cirrhotic rats with hepatopulmonary syndrome. Basic and Clinical Pharmacology and Toxicology 102(4): 370-376

Lopez, B.L.; Snyder, J.W.; Birenbaum, D.S.; Ma, X.I. 1998: N-acetylcysteine enhances endothelium-dependent vasorelaxation in the isolated rat mesenteric artery. Annals of Emergency Medicine 32(4): 405-410

Roberts, R.L.; Ank, B.J.; Falkner, S.; Stiehm, E.R. 1993: N-acetylcysteine enhances the cytotoxicity of neutrophils from normal adults and immunodeficient patients. Clinical Research 41(1): 89A

Beloqui, O.; Prieto, J.; Suarez, M.; Gil, B.; Qian, C.; Garcia, N.; Civeira, P. 1993: N-acetylcysteine enhances the response to lymphoblastoid alpha-interferon in chronic hepatitis C A pilot study. Journal of Hepatology 18(Suppl 1): S51

Giorgi, D.F.; Lobel, D.; Morasco, R.; Shih, R.S.; Meggs, W.J.; Goldfrank, L.R.; Hoffman, R.S. 1994: N-acetylcysteine for pennyroyal oil toxicity. Veterinary and Human Toxicology 36(4): 358

Sisillo,E.; Ceriani,R.; Bortone,F.; Juliano,G.; Salvi,L.; Veglia,F.; Fiorentini,C.; Marenzi,G. 2008: N-acetylcysteine for prevention of acute renal failure in patients with chronic renal insufficiency undergoing cardiac surgery a prospective, randomized, clinical trial. Critical Care Medicine: 1, 81-86

Gillissen, A.; Jaworska, M.; Wiethege, T.; Siegfried, W.; Schultze Werninghaus, G. 1994: N-acetylcysteine functions as an effective glutathione precursor in vitro and in vivo. Atemwegs- und Lungenkrankheiten 20(8): 468-470

Devlin, J.; Ellis, A.; Mcpeake, J.; Wendon, J.; Williams, R. 1994: N-acetylcysteine improves ICG clearance in addition to systemic haemodynamics during severe hepatic dysfunction. Hepatology 20(4 Part 2): 123A

Andrews, N.P.; Husain, S.; Prasad, A.; Husain, M.; Mincemoyer, R.; Panza, J.A.; Cannoni, R.O.I.; Quyyumi, A.A. 1997: N-acetylcysteine improves coronary vascular endothelial dysfunction. Journal of the American College of Cardiology 29(2 Suppl A): 444A

Tsuyuki, S.; Yamauchi, A.; Nakamura, H.; Nakamura, Y.; Kinoshita, K.; Gomi, T.; Kawai, Y.; Hirose, T.; Furuke, K.; Ikai, I.; Ohmori, K.; Yamaoka, Y.; Inamoto, T. 1998: N-acetylcysteine improves cytotoxic activity of cirrhotic rat liver-associated mononuclear cells. International Immunology 10(10): 1501-1508

Zala, G.; Wirth, H.P.; Schwery, S.; Flury, R.; Wurst, J.; Meyenberger, C.; Ammann, R. 1994: N-acetylcysteine improves eradication of H pylori by omeprazole/amoxicillin in cigarette smokers. Gastroenterology 106(4 Suppl): A216

Lindstrom, M.; Lundback, B.; Lundqvist, A.; Jonsson, E.; Sandstrom, T. 1996: N-acetylcysteine improves quality of life in chronic bronchitis. European Respiratory Journal Suppl 9(23): 305S-306S

Holt, S.; Marley, R.; Fernando, B.; Moore, K. 1998: N-acetylcysteine improves renal function in the hepatorenal syndrome. Journal of the American Society of Nephrology 9(Program and Abstr. Issue): 132A

Colombo, A.A.; Bernasconi, P.; Alessandrino, E.P.; Martinelli, G.; Biaggi, G.; Bernasconi, C. 1996: N-acetylcysteine in the treatment of acute graft versus host disease. Blood 88(10 Suppl 1 Part 1-2): 261B

Uthman, B.M.; Hurd, R.W.; Helveston, W.R.; Malone, J.E.; Wilder, B.J. 1995: N-acetylcysteine in the treatment of five siblings with hereditary spinocerebellar ataxia. Neurology 45(4 Suppl 4): A185-A186

Hurd, R.W.; Wilder, B.J.; Pippenger, C.E.; Uthman, B.M. 1995: N-acetylcysteine in the treatment of neurodegenerative disease Eighteen-month follow-up in patients with progressive myoclonus epilepsy. Neurology 45(4 Suppl 4): A181

Uzunalimoglu, O.; Cinar, K.; Erekul, S.; Bozkaya, H.; Bozdayi, A.M.; Koc, O.; Yurdaydin, C. 1998: N-acetylcysteine in thioacetamide induced toxic hepatitis in rats. Hepatology 28(4 Part 2): 630A

Wilder, B.J.; Hurd, R.W.; Uthman, B.M. 1994: N-acetylcysteine in treatment of neurodegenerative disease with altered superoxide dismutase activity. Neurology 44(4 Suppl 2): A178

Arora, P.; Lucchesi, P.A.; Wurster, R.D. 1998: N-acetylcysteine inhibits growth of astrocytoma cells. Proceedings of the American Association for Cancer Research Annual Meeting 39: 120

Lojeski, E.W.; Haney, J.A.; Karan, S.M. 1995: N-acetylcysteine is ineffective in the treatment or prophylaxis of malignant hyperthermia in swine. Anesthesiology 83(3A): A353

Yan, C.Y.I.; Greene, L.A. 1997: N-acetylcysteine maintains PC12 cell survival through activation of the Ras pathway. Society for Neuroscience Abstracts 23(1-2): 1718

Steinberg, E.N. 1996: N-acetylcysteine may improve clinical outcome in acute alcoholic hepatitis. Gastroenterology 110(4 Suppl): A1334

Gilman, A.; Spero, D.E. 1993: N-acetylcysteine methyl ester An efficient sulfur transfer agent. Tetrahedron Letters 34(11): 1751-1752

Barrios, V.; Calderon, A.; Palma, J.L.; Navarro, J.; Asin, E.; Ruilope, L.M.; Lahera, V. 1997: N-acetylcysteine potentiates the antihypertensive effect of ACE inhibitors in a smoker hypertensive population. Journal of the American College of Cardiology 29(2 Suppl A): 189A-190A

Primiano, M.; Palm, D.; Johanson, C.; Knuckey, N.W. 1993: N-acetylcysteine prevents hippocampal neuronal death induced by transient cerebral ischemia. Society for Neuroscience Abstracts 19(1-3): 883

Lee, L.A.; Prescott, W.; Picco, M.; Scheffel, U.A.; Finley, P. 1997: N-acetylcysteine prolongs survival from fulminant hepatitis by inhibiting apoptosis. Hepatology 26(4 Part 2): 366A

Zhang-Feng-Xiang; Chen-Ming-Long; Yang-Bing; Chen-Hong-Wu; Cao-Ke-Jiang 2008: N-acetylcysteine promoted aging through adjusting expression of cell cycle related protein in neonatal SD rat cardiomyocytes. Zhonghua Xinxueguanbing Zazhi 36(2): 146-150

Vendemiale, G.; Grattagliano, I.; Didonna, D.; Altomare, E. 1998: N-acetylcysteine protects hepatic mitochondria from oxidative alterations in bile duct ligated rats. Journal of Hepatology 28(Suppl 1): 78

Hess, D.C.; Wakade, M.; Melvin, J.; Sprinkle, A.; Carroll, J.; Sekul, E. 1997: N-acetylcysteine reduces infarct size in a transient middle cerebral artery occlusion model. Stroke 28(1): 257

Garfinkel, M.R.; Ballard, T.; Opara, E.C. 1996: N-acetylcysteine reduces intralipid-induced glutathione depletion. Gastroenterology 110(4 Suppl): A802

Wright, R.O.; Magnani, B.; Shannon, M.W.; Woolf, A.D. 1996: N-acetylcysteine reduces methemoglobin An in vitro model. Pediatric Research 39(4 Part 2): 164A

Wright, R.O.; Magnani, B.; Shannon, M.W.; Woolf, A.D. 1997: N-acetylcysteine reduces methemoglobin in an in vitro model of glucose-6-phosphate dehydrogenase. Pediatric Research 41(4 Part 2): 63A

Mohanraj, P.; Diaz, P.T.; Clanton, T.L. 1996: N-acetylcysteine reduces the loss of contractile function in severely hypoxic skeletal muscle. FASEB Journal 10(3): A2

Breithaupt, T.; Eylar, E.H.; Baez, I.; Vasquez, A.; Colon Martinez, S.; Rodriguez, J.; Kesseler, M. 1996: N-acetylcysteine reverses the suppressed mitogenic responses of CD4+ and CD8+ T cells from aged rhesus monkeys. FASEB Journal 10(6): A1320

Silva, L.A.; Silveira, P.C.L.; Pinho, Céber.A.; Tuon, T.; Dal Pizzol, F.; Pinho, R.A. 2008: N-acetylcysteine supplementation and oxidative damage and inflammatory response after eccentric exercise. International Journal of Sport Nutrition and Exercise Metabolism 18(4): 379-388

Bagnicka,E.; Jozwik,A.; Strzakowska,N.; Sliwa-Jozwik,A.; Krzyzewski,J.; Koataj,A. 2008: N-acetylcysteine supplementation may affect somatic cell count in goat milk. Archiv Fur Tierzucht: 6, 582-587

Pizzulli, L.; Ewig, S.; Hagendorff, A.; Manz, M.; Luederitz, B. 1994: N-acetylcysteine to prevent nitroglycerin tolerance hemodynamic assessment and neurohormonal counterregulation. European Heart Journal 15(ABSTR Suppl ): 16

Morissey, J.; Tolley, T.; Klahr, S. 1998: N-acetylcysteine treatment affects monocyte adhesion. Journal of the American Society of Nephrology 9(Program and Abstr. Issue): 482A

Bryne, M.; Rye, P.D. 1997: N-acetylgalactosamine containing glycoconjugates and the invasive and metastatic capacity of melanoma cell lines. Tumor Biology 18(Suppl 2): 75

IIda, S.I.; Yamamoto, K.; Sano, Y.; Irimura, T. 1997: N-acetylgalactosamine transfer to MUC-2 tandem repeat peptides by lysates of LS174T colon carcinoma cell. Glycoconjugate Journal 14(6): 774-775

Wong, C H. 1996: N-acetylgalactosaminyl or N-acetylglucosaminyl transfer using N-acetylglucosaminyl-1-phosphate or N-acetylgalactosaminyl-1-phosphate as precursor and glycosyl-nucleotide regeneration. Official Gazette of the United States Patent and Trademark Office Patents 1186(2): 1176

Sato, T.; Kobata, A.; Aoki, N.; Matsuda, T.; Furukawa, K. 1993: N-acetylgalactosaminylation of sugar chains regulated by lactogenic hormones in bovine mammary epithelial cell glycoproteins. Cell Structure and Function 18(6): 616

Scocca, J.; Zou, J.; Krag, S.S. 1992: N-acetylglucosamine-1-phosphate transferase of Chinese hamster ovary cells is stably expressed in Schizosaccharomyces pombe and can functionally replace the Schizosaccharomyces pombe gene. Glycobiology 2(5): 482

Law, M.P.; Lund, C.V.; Toler, R.A.; Luhm, M.J.; Goode, C.A. 1997: N-acetylglucosaminidase activity in eggs of Ascidia ceratodes. FASEB Journal 11(9): A1159

Marschall, H.U.; Wietholtz, H.; Goetze, U.; Roder, G.; Matern, H.; Sjovall, J.; Matern, S. 1992: N-acetylglucosaminides are major urinary metabolites of orally given ursodeoxycholic acid in healthy humans. Hepatology 16(4 Part 2): 257A

Taniguchi, N.; Nishikawa, A.; Yamaguchi, N. 1998: N-acetylglucosaminyl transferase gene coding therefor and process for production thereof. Official Gazette of the United States Patent and Trademark Office Patents 1206(2): 1350

Yamamoto, H.; Kersey, D.; Akama, K.; Nishikawa, A.; Taniguchi, N.; Moskal, J. 1994: N-acetylglucosaminyltransferase III and V mRNA expression in human brain tumors. Proceedings of the American Association for Cancer Research Annual Meeting 35: 214

Akama, R.; Sato, Y.; Kariya, Y.; Isaji, T.; Fukuda, T.; Lu, L.; Taniguchi, N.; Ozawa, M.; Gu, J. 2008: N-acetylglucosaminyltransferase IIi expression is regulated by cell-cell adhesion via the E-cadherin-catenin-actin complex. Proteomics 8(16): 3221-3228

Pierce, J.M.; Shoreibah, M.G.; Adler, B.S.; Fregien, N.L. 1997: N-acetylglucosaminyltransferase V gene. Official Gazette of the United States Patent and Trademark Office Patents 1195(2): 1166

Yang, X.; Li, J.; Geng, M. 2008: N-acetylglucosaminyltransferase V modifies TrKA protein, regulates the receptor function. Cellular and Molecular Neurobiology 28(5): 663-670

Hession,A.O.; Esrey,E.G.; Croes,R.A.; Maxwell,C.A. 2008: N-acetylglutamate and N-acetylaspartate in soybeans , maize , and other foodstuffs. Journal of Agricultural and Food Chemistry 56: 9121-9126

Roer, R.D.; Butler, K.D. 1997: N-acetylhexosaminidase activity in the postecdysial cuticle of the blue crab - a role in the initiation of mineralization. American Zoologist 37(5): 140A

Amorelli, B.; Yang, C.; Rempel, B.; Withers, S.G.; Knapp, S. 2008: N-Acetylhexosaminidase inhibitory properties of C-1 homologated GlcNAc- and GalNAc-thiazolines. Bioorganic and Medicinal Chemistry Letters 18(9): 2944-2947

Ihle, E.C.; Schwartz, E.A. 1994: N-acetylhistidine buffers pH during synaptic transmission in the Bufo marinus retina. IOVS Investigative Ophthalmology and Visual Science 35(4): 1363

Kragl, U.; Kittelmann, M.; Ghisalba, O.; Wandrey, C. 1995: N-acetylneuraminic acid From a rare chemical from natural sources to a multikilogram enzymatic synthesis for industrial application. Legoy, M -D , Thomas, D Annals of the New York Academy of Sciences; Enzyme engineering XII 300-305

Han, Y.; Kim, K.; Shim, J-Young.; Park, C.; Song, J-Young.; Yun, Y-Sook. 2008: N-acetylphytosphingosine enhances the radiosensitivity of lung cancer cell line NCI-H460. Molecules and Cells 25(2): 224-230

Leblanc, M.; Pichette, V.; Madore, F.; Ouimet, D.; Geadah, D.; Cardinal, J. 1995: N-acetylprocainamide intoxication with torsade de pointes treated by high dialysate flow rate continuous arteriovenous hemodiafiltration. Critical Care Medicine 23(3): 589-593

Ambrosone, C.B.; Freudenheim, J.L.; Marshall, J.R.; Graham, S.; Vena, J.E.; Brasure, J.R.; Michalek, A.M.; Bowman, E.D.; Harrington, A.M.; Shields, P.G. 1995: N-acetyltransferase , cigarette smoking, and breast cancer risk. Proceedings of the American Association for Cancer Research Annual Meeting 36: 283

Roemer, H.C.; Weistenhofer, W.; Lohlein, D.; Geller, F.; Blomeke, B.; Golka, K. 2008: N-acetyltransferase 1 in colon and rectal cancer cases from an industrialized area. Journal of Toxicology and Environmental Health. Part A 71(13-14): 902-905

Juhanson, P.; Kepp, K.; Org, E.; Veldre, G.; Kelgo, P.; Rosenberg, M.; Viigimaa, M.; Laan, M. 2008: N-acetyltransferase 8, a positional candidate for blood pressure and renal regulation: resequencing, association and in silico study. Bmc Medical Genetics 9: 25

Zheng, W.; Deitz, A.; Campbell, D.; Wen, W.Q.; Sellers, T.; Cerhan, J.; Folsom, A.; Hein, D. 1998: N-acetyltransferase I genetic polymorphisms, cigarette smoking, well-done meat intake, and the risk of breast cancer. Anticancer Research 18(5C): 3887

Pronko, P.; Lindros, K.O.; Eriksson, C.J.P. 1998: N-acetyltransferase activity in the alcohol preferring AA and alcohol avoiding ANA rat lines. Alcoholism Clinical and Experimental Research 22(3 ABSTR Suppl ): 186A

Jones, R.F.; Debiec Rychter, M.; Schut, H.J.; Morse, P.; Haas, G.P.; Wang, C.Y. 1998: N-acetyltransferase expression and heterocyclic amine adduct formation in human prostate. Proceedings of the American Association for Cancer Research Annual Meeting 39: 635

Chern, H.D.; Persad, R.A.; Fleming, C.M.; Bryant, J.L.; Romkes Sparks, M.; Sibley, G.A.; Smith, P.J.B.; Branch, R.A. 1995: N-acetyltransferase slow acetylator phenotype increases susceptibility to occupational related aggressive bladder cancer. Proceedings of the American Association for Cancer Research Annual Meeting 36: 121

Hanna, P.E. 1994: N-acetyltransferases, O-acetyltransferases, and N,O-acetyltransferases: enzymology and bioactivation. Advances in Pharmacology 27: 401-430

Van Goudoever, J.B.; Sulkers, E.J.; Broerse, H.M.; Carnielli, V.P.; Sauer, P.J.J. 1992: N-acetyltyrosine and acetylcystine An alternative to low intake of tyrosine and cystine in neonatal total parenteral nutrition ?. Pediatric Research 32(5): 626

Vecchietti, V.; Colle, R.; Dondio, G.; Giardina, G. 1994: N-acryl-substituted azacyclic compounds, processes for their preparation, and their use as pharmaceuticals. Official Gazette of the United States Patent and Trademark Office Patents 1168(4): 2571

Nakamura, N.; Ohkawa, N.; Oshima, T.; Miyamoto, M.; IIjima, Y. 1996: N-acryloylpiperazine compounds. Official Gazette of the United States Patent and Trademark Office Patents 1190(3): 2068-2069

Nakamura, N.; Ohkawa, N.; Oshima, T.; Miyamoto, M.; IIjima, Y. 1994: N-acryloylpiperazine derivatives, their preparation and their use of paf antagonists. Official Gazette of the United States Patent and Trademark Office Patents 1168(5): 3333

Tjoeng, F.S.; Toth, M.V. 1998: N-acyl beta amino acid derivatives useful as platelet aggregation inhibitors. Official Gazette of the United States Patent and Trademark Office Patents 1206(3): 2197

Della, V., F.; Lorenzi, S.; Samson, J.C.J.J.; Della, V., F. 1996: N-acyl derivatives of aminoalcohols active as local autacoids and useful in the therapy of autoimmune processes. Official Gazette of the United States Patent and Trademark Office Patents 1185(2): 1197

Della, V., F.; Lorenzi, S.; Marcolongo, G. 1997: N-acyl derivatives of aminoalcohols with polycarboxylic acids able to modulate mast cells in inflammatory processes having neuroimmunogenic origin. Official Gazette of the United States Patent and Trademark Office Patents 1197(2): 1155-1156

Drauz, K.; Knaup, G.; Groeger, U. 1996: N-acyl dipeptides and their compositions. Official Gazette of the United States Patent and Trademark Office Patents 1188(2): 1271-1272

Frey, C.; Griffith, O.W. 1996: N-acyl guanidines; A new class of nitric oxide synthase inhibitors. FASEB Journal 10(6): A1399

Heys, S.J.D.; Mullen, R.; Gilbert, P.; Allison, D.G. 1997: N-acyl homoserine lactones and bacterial biofilms. Journal of Pharmacy and Pharmacology 49(Suppl 4): 6

Capet, M.; Dubroeucq, M C. 1997: N-acyl pyrrolidines and drugs for the treatment or prevention of cholecystokinin and gastrin-related disorders. Official Gazette of the United States Patent and Trademark Office Patents 1197(5): 3272-3273

Crudden, J.J. 1996: N-acyl sarcosinates Effective, ecofriendly adjuvants for pesticide formulation. Abstracts of Papers American Chemical Society 211(1-2): AGRO 194

Lombardo, L.J. 1995: N-acyl substituted phenyl piperidines as bronchodilators and antiinflammatory agents. Official Gazette of the United States Patent and Trademark Office Patents 1179(3): 1829

Keavy, D.J.; Parker, M.F.; Mattson, R.J.; Johnson, G. 1998: N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics. Official Gazette of the United States Patent and Trademark Office Patents 1210(3): 2632-2633

Andrasi, F.; Berzsenyi, P.; Botka, P.; Farkas, S.; Goldschmidt, K.; Hamori, T.; Korosi, J.; Moravcsik, I.; Tarnawa, I. 1996: N-acyl-2,3-benzodiazepine derivatives and a method of treating spasms of the skeletal musculature therewith. Official Gazette of the United States Patent and Trademark Office Patents 1186(4): 2804

Andrasi, F.; Berzsenyl, P.; Botka, P.; Farkas, S.; Goldschmidt, K.; Hamori, T.; Korosi, J.; Moravcsik, I.; Tarnawa, I. 1997: N-acyl-2,3-benzodiazepine derivatives for treating acute and chronic neurodegenerative disorders. Official Gazette of the United States Patent and Trademark Office Patents 1199(3): 1928

Andrasi, F.; Berzsenyi, P.; Botka, P.; Farkas, S.; Goldschmidt, K.; Hamori, T.; Korosi, J.; Moravcsik, I.; Tarnawa, I. 1996: N-acyl-2,3-benzoidazepine derivatives, pharmaceutical compositions containing them and process for preparing same. Official Gazette of the United States Patent and Trademark Office Patents 1186(3): 2018-2019

Zenker, L.; Wunderlich, H.; Lohmann, D.; Rostock, A.; Siegemund, C.; Valdman, A.V.; Voronina, T.A.; Rachmankulova, I.C.; Glozman, O.M.; Garibova, T.L.; Mescerjakova, L.M.; Zmurenko, L.A.; Seredenin, S.B.; Rozancev, G.G. 1995: N-acyl-4-phenyl-pyrrolidin-2-ones and method for preparing. Official Gazette of the United States Patent and Trademark Office Patents 1177(3): 1769

Schmidlin, T.; Zbinden, P.; Buehlmayer, P. 1997: N-acyl-N-heterocyclylalkylamino acid compounds and method of use thereof. Official Gazette of the United States Patent and Trademark Office Patents 1197(3): 1909

Paik, S.; White, E.H. 1994: N-acyl-N-nitrosoamino acids and peptides. Tetrahedron Letters 35(42): 7731-7734

Takematsu, T.; Kume, T.; Komata, T.; Suzuki, K.; Ikeda, Y.; Kawamura, M.; Mori, K. 1996: N-acyl-N-phenylmaleamic acid derivatives, methods of producing same, and herbicides containing same as effective components. Official Gazette of the United States Patent and Trademark Office Patents 1185(4): 2705

Takematsu, T.; Komata, T.; Kume, T.; Suzuki, K.; Kawamura, M.; Shirakawa, Y.; Mori, K. 1995: N-acyl-N-phenyltetrahydrophthalamic acid derivatives, methods of producing same, and herbicides containing same as effective components. Official Gazette of the United States Patent and Trademark Office Patents 1180(3): 1783

Schmidlin, T.; Zbinden, P.; Buehlmayer, P. 1996: N-acyl-N-quinolinyl or isoquinounyl alkylamino acids compositions and method of use. Official Gazette of the United States Patent and Trademark Office Patents 1185(2): 1204-1205

Metzger, J.; Wiesmueller, K H.; Jung, G. 1997: N-acyl-S- cysteines, their preparation and their use as intermediates for the preparation of synthetic immuno-adjuvants and synthetic vaccines. Official Gazette of the United States Patent and Trademark Office Patents 1205(4): 3097

Mattson, R.J.; Keavy, D.J.; Parker, M.F.; Johnson, G. 1997: N-acyl-cycloalkylamine derivatives as melatonergics. Official Gazette of the United States Patent and Trademark Office Patents 1194(3): 1959

Ptchelintsev, D. 1997: N-acyl-ethylene-triacetic acids. Official Gazette of the United States Patent and Trademark Office Patents 1197(3): 1912

Wood, D.W.; Pierson, E.A.; Cannon, J.A.; Pierson, L.S.IIi 1997: N-acyl-homoserine lactone mediates intra- and interpopulation signaling in the rhizosphere. Abstracts of the General Meeting of the American Society for Microbiology 97: 310

Morishima, H.; Koike, Y.; Nakano, M.; Atsuumi, S.; Tanaka, S.; Matsuyama, K. 1996: N-acylamino acid derivatives and their use. Official Gazette of the United States Patent and Trademark Office Patents 1185(2): 1243-1244

Boeckh, J.; Hoever, F.P.; Krueger, B.W.; Nentwig, G.; Roeder, K. 1996: N-acylated 2- -piperidines A new class of insect and tick repellents. Abstracts of Papers American Chemical Society 212(1-2): AGRO 20

Bazan, N.G.; Gomez, J.A. 1996: N-acylated 4-hydroxphenylamine derivatives with analgesic properties and pharmaceutical compositions containing them. Official Gazette of the United States Patent and Trademark Office Patents 1190(2): 1261

Berger, C.; Gacon, P. 1995: N-acylated derivatives of mixtures of amino acids derived from hydrolysates of cereal proteins and their applications. Official Gazette of the United States Patent and Trademark Office Patents 1179(3): 1749

Fahmy, M.A.H.; Harrison, C.R.; Lahm, G.P.; Stevenson, T.M. 1997: N-acylated pyrazolines. Official Gazette of the United States Patent and Trademark Office Patents 1194(1): 453

Fahmy, M.A.H.; Harrison, C.R.; Lahm, G.P.; Stevenson, T.M. 1996: N-acylated pyrazolines, compositions and use. Official Gazette of the United States Patent and Trademark Office Patents 1183(2): 863

Pecar, S.; Sollner, M.; Urleb, U.; Kikelj, D.; Marc, G.; Krbavcic, A.; Kotnik, V.; Wraber Herzog, B.; Simcic, S.; Ihan, A.; Klamfer, L.; Povsic, L.; Kopitar, Z.; Stalc, A. 1996: N-acyldipeptides, processes for the preparation thereof and pharmaceutical compositions containing the same. Official Gazette of the United States Patent and Trademark Office Patents 1186(1): 431

Honda, S.; Torii, K.; Arai, Y.; Kasai, M.; Kato, H.; IIda, T.; Takahashi, T.; Yokoo, Y.; Kamiya, T.; Tamaoki, T. 1995: N-acylglutamine derivatives and cosmetic compositions. Official Gazette of the United States Patent and Trademark Office Patents 1180(3): 1717

Merkler, D.J.; Asser, A.S.; Deblassio, J.L.; Gee, A.J.; Johnson, M.E.; Liang, H.; Merkler, K.A.; Chowdury, S.R.y 1997: N-acylglycines as substrates for peptidylglycine alpha-amidating enzyme. FASEB Journal 11(9): A1135

Gillum, M.P.; Zhang, D.; Zhang, X.-M.; Erion, D.M.; Jamison, R.A.; Choi, C.; Dong, J.; Shanabrough, M.; Duenas, H.R.; Frederick, D.W.; Hsiao, J.J.; Horvath, T.L.; Lo, C.M.; Tso, P.; Cline, G.W.; Shulman, G.I. 2008: N-acylphosphatidylethanolamine, a gut- derived circulating factor induced by fat ingestion, inhibits food intake. Cell 135(5): 813-824

Blochet, J.E.; Pezolet, M. 1993: N-acylphosphatidylethanolamines Effect of the chain length on the orientation of the N-acyl chain. Biophysical Journal 64(2 Part 2): A294

Ghyczy, M. 1996: N-acylphosphatidylethanolamines as anti-oxidants. Official Gazette of the United States Patent and Trademark Office Patents 1187(1): 446

Maccoss, M.; Mills, S.G. 1997: N-acylpiperidine tachykinin antagonists. Official Gazette of the United States Patent and Trademark Office Patents 1196(2): 1160-1161

Capet, M.; Dubroeucq, M C.; Manfre, F. 1998: N-acylpyrrolidines and medicaments for the treatment or prevention of disorders linked to CKK and to gastrin. Official Gazette of the United States Patent and Trademark Office Patents 1206(2): 1394-1395

Morozov, I.S.; Klimova, N.V.; Lavrova, L.N.; Avdyunina, N.I.; Pyatin, B.M.; Troitskaya, V.S.; Bykov, N.P. 1998: N-adamantyl derivatives of aromatic amines Communication I Synthesis and neurotropic activity of N- anilines. Khimiko-Farmatsevticheskii Zhurnal 32(1): 3-6

Horishita, T.; Harris, R.A. 2008: N-Alcohols inhibit voltage-gated Na+ channels expressed in Xenopus oocytes. Journal of Pharmacology and Experimental Therapeutics 326(1): 270-277

Sandberg, R.E.; Adams, D.C.; Klopfenstein, T.J.; Grant, R.J. 1998: N-alkane as an internal marker for predicting digestibility of forages. Journal of Dairy Science 81(Suppl 1): 201

Bugalho, M.N.; Milne, J.A.; Mayes, R.W.; Rego, F.C. 1998: N-alkanes as markers for determining the diet of red deer grazing on Mediterranean type vegetation in southern Portugal. Revista de Biologia 16(1-4): 223

Li, P.K.; Chu, G.H.; Milano, S.; Kluth, L.; Rhodes, M. 1996: N-alkanoyl benzene as nonsteroidal estrone sulfatase inhibitors. Abstracts of Papers American Chemical Society 212(1-2): MEDI 47

Baccolini, G.; Gianelli, M. 1995: N-alkenyl-3,5-pyrazolidinediones from ketone hydrazones, PCl-3 and malonic acid. Tetrahedron 51(34): 9487-9492

Heinemann, U.; Krueger, B W.; Tiemann, R.; Dutzmann, S.; Stenzel, K. 1998: N-alkoxy-amidine derivatives. Official Gazette of the United States Patent and Trademark Office Patents 1208(3): 2381

Galema, S.A.; Engberts, J.B.F.N.; Van Doren, H.A. 1994: N-alkyl 1-thio-D-glycopyranosides The influence of stereochemistry on synthesis, purification, liquid crystalline behavior, solubility and aggregate morphology in water. Abstracts of Papers American Chemical Society 207(1-2): CARB 112

Berlin, K.D.; Garrison, G.L.; Sangiah, S.; Clarke, C.R.; Chen, C L.; Lazzara, R.; Scherlag, B.J.; Patterson, E.S.; Burrows, G.E. 1995: N-alkyl and N-acyl derivatives of 3,7-diazabicyclo- nonanes and selected salts thereof as multi-class antiarrhythmic agents. Official Gazette of the United States Patent and Trademark Office Patents 1180(3): 1824

Stark, H.; Kiec Kononowicz, K.; Reidermeister, S.; Moty, M.; Ligneau, X.; Garbarg, M.; Schwartz, J.C.; Schunack, W. 1996: N-alkyl carbamates as potent and selective histamine H3-receptor antagonists. European Journal of Pharmaceutical Sciences 4(Suppl ): S79

Steltenkamp, R.J. 1995: N-alkyl neotridecanamide insect repellents. Official Gazette of the United States Patent and Trademark Office Patents 1176(3): 1896

Tian, Y.M.; Griffiths, D.E. 1994: N-alkyl pyridiniums as inhibitors of complex 1. Biochemical Society Transactions 22(1): 71s

Ingall, A.H.; Cage, P.A.; Kindon, N.D. 1998: N-alkyl-2-substituted ATP analogues and administration to inhibit platelet aggregation. Official Gazette of the United States Patent and Trademark Office Patents 1207(4): 2946

Samaritoni, J.G.; Arndt, L.; Bruce, T.J.; Dripps, J.E.; Gifford, J.; Hatton, C.J.; Hendrix, W.H.; Schoonover, J.R.; Johnson, G.W.; Hedge, V.B.; Thornburgh, S. 1997: N-alkyl-N- - and N- -phenylacetamides Synthesis and biological activity. Journal of Agricultural and Food Chemistry 45(5): 1920-1930

Reizlein, K.; Engelhardt, U.; Horstmann, H O.; Singer, R J.; Wangermann, K.; Wirth, W. 1994: N-alkyl-lactams as crystallization inhibitors. Official Gazette of the United States Patent and Trademark Office Patents 1168(5): 3337

Parenti, M. 1996: N-alkyl-taurourodeoxycholic acids and their therapeutically active derivatives. Official Gazette of the United States Patent and Trademark Office Patents 1184(3): 1739

Shan, J.H.; Nowak, G.; Izenwasser, S.; Witkin, J.M.; Newman, A.H.; (Usa), D.D.velop Group 1994: N-alkylaminobenzazepine analogs are highly selective dopamine-D-1 receptor antagonists. Abstracts of Papers American Chemical Society 208(1-2): MEDI 174

Moerlein, S.M.; Perlmutter, J.S.; Bockhorst, J.L.; Parkinson, D.; Welch, M.J. 1994: N-alkylated analogues of benperidol as dopaminergic D-2 receptor ligands. Journal of Labelled Compounds and Radiopharmaceuticals 35: 462-463

Goerlitzer, K.; Roth, A. 1995: N-alkylated and annulated pyridine derivatives from amino acids, Part 2 Oxazolo- and thiazolo pyridines. Pharmazie 50(11): 729-732

Yang, B.; Johnston, D.; Luedtke, R.R.; Mach, R.H. 1996: N-alkylated azabicyclononanes benzamides ad dopamine D-2/D-3 receptor ligands. Abstracts of Papers American Chemical Society 212(1-2): MEDI 148

Berkov, S.; Codina, C.; Viladomat, F.; Bastida, J. 2008: N-Alkylated galanthamine derivatives: Potent acetylcholinesterase inhibitors from Leucojum aestivum. Bioorganic and Medicinal Chemistry Letters 18(7): 2263-2266

Zhang, Y.; Tian, Z.; Kowalczuk, M.; Edwards, P.; Roeske, R.W. 1993: N-alkylation of pyridylalanine and pyridinecarboxylic acids and their use in synthesis of GnRH antagonists. Tetrahedron Letters 34(23): 3659-3662

Lin, J.Y.; Yang, M.H. 1994: N-alkylcarbamoyl derivatives of amino acids as chiral stationary phases for high-performance liquid chromatography I An example of enhancing enantioselectivity by deleting the non-enantioselective pi-pi interaction site on the chiral stationary phase. Journal of Chromatography A 684(1): 13-21

Edmonds Alt, X.; Martinez, S.; Proietto, V.; Van, B., D. 1995: N-alkylenepiperidino compounds, their enantiomers and pharmaceutical compositions. Official Gazette of the United States Patent and Trademark Office Patents 1174(1): 413-414

Levit, G.L.; Radina, L.B.; Krasnov, V.P. 1995: N-alkylnitrosocarbamoyl derivatives of amino acids Synthesis, properties and antitumor activity A review. Khimiko-Farmatsevticheskii Zhurnal 29(8): 10-17

Gaster, L.M.; Joiner, G.F.; Mulholland, K.R.; Wyman, P.A. 1998: N-alkylpiperidinyl-4-methyl carboxylic esters/amides of condensed ring systems as 5-HT4 receptor antagonists. Official Gazette of the United States Patent and Trademark Office Patents 1208(2): 1431-1432

Baudy, R.B.; Berta, S.C. 1995: N-alkynyl carboxamides as sertonergic agents. Official Gazette of the United States Patent and Trademark Office Patents 1178(3): 1681

Kessler, R.M.; Mason, N.S.; Ansari, M.S.; De Paulis, T.; Clanton, J.A.; Manning, R.G.; Holburn, G.; Forrester, J.W. 1994: N-allyl epidepride An extremely potent SPECT radioligand for the dopamine D2 receptor. Journal of Nuclear Medicine 35(5 Suppl): 199P

Steardo, L.; Monteleone, P.; d'Istria, M.; Serino, I.; Maj, M.; Cuomo, V. 1995: (+)-N-allylnormetazocine enhances N-acetyltransferase activity and melatonin synthesis: preliminary evidence for a functional role of sigma receptors in the rat pineal gland. Journal of Pharmacology and Experimental Therapeutics 275(2): 845-849

Bliss, P.W.; Calam, J. 1997: N-alpha methyl histamine in the gastric lumen stimulates acid secretion in human volunteers. Gastroenterology 112(4 Suppl): A72

Gordeev, M.F.; Patel, D.V.; Barker, P.L.; Gordon, E.M. 1994: N-alpha-Fmoc-4-phosphono -L-phenylalanine A new O-phosphotyrosine isosteric building block suitable for direct incorporation into peptides. Tetrahedron Letters 35(41): 7585-7588

D.B.ee, F.M.; Van Leeuwen, F.W.; Burbach, J.P.H. 1992: N-alpha-acetylated vasopressin in the rat pituitary gland and hypothalamus. Society for Neuroscience Abstracts 18(1-2): 1368

Curran, T.P.; Chandler, N.M.; Kennedy, R.J.; Keaney, M.T. 1996: N-alpha-benzoyl-cis-4-amino-L-proline A gamma-turn mimetic. Tetrahedron Letters 37(12): 1933-1936

Zhang, Z.; Yu, Y.; Liebeskind, L.S. 2008: N-amidation by copper-mediated cross-coupling of organostannanes or boronic acids with o-acetyl hydroxamic acids. Organic Letters 10(14): 3005-3008

Chen, X.; Yuan, J. 1997: N-aminoalkyl-1-biphenylenyl-2-carboxamides; new dopamine receptor subtype specific ligands. Official Gazette of the United States Patent and Trademark Office Patents 1205(5): 3909

Chen, X.; Wasley, J.W.F. 1997: N-aminoalkyl-2-anthraquinonecarboxamides; new dopamine receptor subtype specific ligands. Official Gazette of the United States Patent and Trademark Office Patents 1205(5): 3954

Masaki, M.; Miyake, N.; Tendo, A.; Takeda, H.; Ishida, M.; Shinozaki, H. 1996: N-aminoalkyl-substituted nitrogen-containing five membered heterocyclic compounds. Official Gazette of the United States Patent and Trademark Office Patents 1192(2): 1252

Yuan, J.; Chen, X. 1998: N-aminoalkyldibenzofurancarboxamides; new dopamine receptor subtype specific ligands. Official Gazette of the United States Patent and Trademark Office Patents 1206(3): 2230

Yuan, J.; Chen, X. 1997: N-aminoalkylfluorenecarboxamides A new class of dopamine receptor subtype specific ligands. Official Gazette of the United States Patent and Trademark Office Patents 1201(3): 2180

Njie, Y.Fatou.; Qiao, Z.; Xiao, Z.; Wang, W.; Song, Z-Hui. 2008: N-arachidonylethanolamide-induced increase in aqueous humor outflow facility. IOVS Investigative Ophthalmology and Visual Science 49(10): 4528-4534

Munk, S.A.; Harcourt, D.; Arasasingham, P.; Manlapaz, C.; Kharlamb, A.; Padillo, E.; Roberts, D.; Runde, E.; Williams, L.; Gil, D.; Burke, J.; Wheeler, L.; Garst, M. 1996: N-aryl aminoimidazoles Synthesis and evaluation as alpha-2 adrenergic agonists. Abstracts of Papers American Chemical Society 211(1-2): MEDI 22

Beck, J.P.; Bakthavatchalam, R.; Curry, M.A.; Fitzgerald, L.W.; Frietze, W.F.; Gilligan, P.J.; Huang, S.M.; Olson, R.E.; Robertson, D.W.; Shen, H.; Wilde, R.G.; Zaczek, R. 1998: N-aryl aminotriazolopyrimidines as corticotropin releasing hormone antagonists. Abstracts of Papers American Chemical Society 215(1-2): MEDI 140

Baasner, B.; Hagermann, H.; Heil, M.; Lieb, F.; Uhr, H.; Erdelen, C. 1998: N-aryl and N-alkylsulphonylaminals and pesticides. Official Gazette of the United States Patent and Trademark Office Patents 1208(2): 1436

Steltenkamp, R.J. 1995: N-aryl and N-cycloalkyl neoalkanamide insect repellents. Official Gazette of the United States Patent and Trademark Office Patents 1176(3): 1896

Chang, G.; Hamanaka, E.S.; Mccarthy, P.A.; Truong, T.V.; Walker, F.J. 1997: N-aryl and N-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme A Cholesterol acyl transferase. Official Gazette of the United States Patent and Trademark Office Patents 1201(2): 1306-1307

Beard, R.L.; Teng, M.; Colon, D.F.; Duong, T.T.; Chandraratna, R.A. 1998: N-aryl substituted tetrahydroquinolines having retinoid agonist, retinoid antagonist or retinoid inverse agonist type biological activity. Official Gazette of the United States Patent and Trademark Office Patents 1209(2): 1491

Van, H., J.C.; Kleschick, W.A.; Arndt, K.E.; Costales, M.J.; Ehr, R.J.; Bradley, K.B.; Reifschneider, W.; Benko, Z.; Ash, M.L.; Jachetta, J.J. 1997: N-aryl triazolo pyridine-2-sulfonamide herbicides. Official Gazette of the United States Patent and Trademark Office Patents 1205(4): 3105

Jacobson, R.M. 1998: N-aryl-3-aryl-4-substituted-4,5-dihydro-1H-pyrazole-1-carboxamides and methods of their production. Official Gazette of the United States Patent and Trademark Office Patents 1213(4): 3718

Trotto, S.; Furch, J.A.IIi; Kuhn, D.G.; Hunt, D.A. 1996: N-aryl-and N-heteroarylhydrazones of substituted thioacids and thes-oxides thereof as insecticidal and acaricidal agents. Official Gazette of the United States Patent and Trademark Office Patents 1190(3): 2081-2082

Fischer, R.; Jensen Korte, U.; Kunisch, F.; Marhold, A.; Ooms, P.; Schallner, O.; Santel, H J.; Schmidt, R.R.; Krauskopf, B.; Strang, H. 1996: N-aryl-substituted nitrogen-containing heterocycles intermediates and their use as herbicides and plant growth regulators. Official Gazette of the United States Patent and Trademark Office Patents 1190(2): 1241

Van, H., J.C.; Kleschick, W.A.; Arndt, K.E.; Costales, M.J.; Ehr, R.J.; Bradley, K.B.; Reifschneider, W.; Benko, Z.; Jachetta, J.J. 1996: N-aryl1,2,4triazolo1,5-Apyridine-2-sulfonamide herbicides. Official Gazette of the United States Patent and Trademark Office Patents 1192(1): 438-439

Lind, P.T.; Noreen, R.; Morin, J.M.; Ternansky, R.J. 1998: N-arylalkyl-N-heteroarylurea and guandine compounds and methods of treating HIV infection. Official Gazette of the United States Patent and Trademark Office Patents 1217(3): 2605-2606

Park, N S.; Jung, Y S.; Seong, C M.; Lee, J C.; Choi, J I.; Choi, S W.; Choi, Y J.; Lee, K S. 1997: N-arylalkylphenylacetamide derivatives. Official Gazette of the United States Patent and Trademark Office Patents 1202(4): 3123

Takematsu, T.; Kume, T.; Yamaoka, S.; Komata, T.; Suzuki, K.; Ikeda, Y.; Kawamura, M.; Koda, Y.; Mori, K. 1996: N-aryloxyacyl-N-phenyltetrahydrophthalamic acid derivatives, methods of producing same, and herbicides containing same as effective components. Official Gazette of the United States Patent and Trademark Office Patents 1182(1): 466

Pfister, J.R.; Clarke, D.E. 1995: N-aryloxyalkyl tryptamine alpha-1-adrenergic receptor antagonists. Official Gazette of the United States Patent and Trademark Office Patents 1176(4): 2637

James, D.R.; Felix, R.A. 1994: N-benzotriazoles. Official Gazette of the United States Patent and Trademark Office Patents 1168(5): 3324-3325

Matyus, P.; Zara, E.; Farkas, L.; Papp, A.; Simay, A.; Toldy, L.; Andrasi, F.; Goldschmidt, K.; Hodula, E.; Mathe, I.; Sutka, K.; Fittler, Z.; Vitkoczi, V.; Sebestyen, L.; Sziraki, I.; Rusz, M.; Gal, E. 1998: N-benzoyl amino acid derivatives pharmaceutical compositions containing them and process for preparing same. Official Gazette of the United States Patent and Trademark Office Patents 1206(1): 493-494

Srivastava, R.P.; Zjawiony, J.K.; Peterson, J.R.; Mcchesney, J.D. 1994: N-benzoyl- -phenylisoserine methyl ester A facile and convenient synthesis and resolution by entrainment. Abstracts of Papers American Chemical Society 207(1-2): MEDI 84

Matyus, P.; Zara, E.; Farkas, L.; Papp, A.; Simay, A.; Toldy, L.; Andrasi, F.; Goldschmidt, K.; Hodula, E.; Mathe, I.; Sutka, K.; Fittler, Z.; Vitkoczi, V.; Sebestyen, L.; Sziraki, I.; Rusz, M.; Gal, E. 1998: N-benzoylamino acid derivatives, pharmaceutical compositions containing them and process of preparing same. Official Gazette of the United States Patent and Trademark Office Patents 1217(5): 4209

Foguet, R.; Gubert, S.; Sacristan, A.; Ortiz, J.A. 1997: N-benzoylmethyl-piperdines. Official Gazette of the United States Patent and Trademark Office Patents 1202(2): 1374

Lau, C.K.; Black, C.; Guay, D.; Gauthier, J Y.; Leblanc, Y.; Roy, P.; Ducharme, Y.; Hamel, P. 1997: N-benzyl indol-3-yl butanoic acid derivatives as cyclooxygenase inhibitors. Official Gazette of the United States Patent and Trademark Office Patents 1199(3): 1939-1940

Huang, Y.nsheng; Whirrett, Brian; Childers, Steven, R.; Mach, Robert, H. 1997: N-benzyl-4-aminopiperidine phenylacetamide analogues as potent sigma-1/sigma-2 receptor ligands. Abstracts of Papers American Chemical Society 213(1-3): MEDI 55

Lau, C.K.; Black, C.; Guay, D.; Gauthier, J.Y.; Leblanc, Y.; Roy, P.; Ducharme, Y.; Hamel, P. 1997: N-benzylindol-3-yl propanoic acid derivatives as cyclooxygenase inhibitors. Official Gazette of the United States Patent and Trademark Office Patents 1195(3): 1956-1957

Korlipara, V.L.; Takemori, A.E.; Portoghese, P.S. 1994: N-benzylnaltrindoles as long-acting delta-opioid receptor antagonists. Journal of Medicinal Chemistry 37(12): 1882-1885

Amadori, D.; Marangolo, M.; Pacini, P.; Ravaioli, A.; Rossi, A.; Gambi, A.; Catalano, G.; Perrone, D.; Giunchi, D.C.; Becciolini, A.; Volpi, A.; Nanni, O. 1996: N-breast cancer patients Prospective use of tumour proliferative activity for adjuvant therapy. International Journal of Biological Markers 11(2): 132-133

Ebeid, M.Y.; Moussa, B.A.; A Malek, A.; Ashour, F.M. 1998: N-bromosuccinimide as an analytical reagent for the determination of some antihypertensive agents. Egyptian Journal of Pharmaceutical Sciences 38(1-3): 171-182

Cettour, P.; Descotes, G.; Praly, J.P.erre 1995: N-bromosuccinimide-mediated transformations of acetylated 1,5-anhydro-1-C-phenyl-D-hexitols. Journal of Carbohydrate Chemistry 14(3): 445-449

Baek, R.C.; Kasperzyk, J.L.; Platt, F.M.; Seyfried, T.N. 2008: N-butyldeoxygalactonojirimycin reduces brain ganglioside and GM2 content in neonatal Sandhoff disease mice. Neurochemistry International 52(6): 1125-1133

Pollock, S.; Dwek, R.A.; Burton, D.R.; Zitzmann, N. 2008: N-Butyldeoxynojirimycin is a broadly effective anti-HIV therapy significantly enhanced by targeted liposome delivery. Aids 22(15): 1961-1969

Fukuzawa, T.; Obika, M. 1994: N-cadherin expression is lost when neural crest cells differentiate into melanophores in Xenopus laevis. Pigment Cell Research 7(5): 371

Haug, J.S.; He, X.C.; Grindley, J.C.; Wunderlich, J.P.; Gaudenz, K.; Ross, J.T.; Paulson, A.; Wagner, K.P.; Xie, Y.; Zhu, R.; Yin, T.; Perry, J.M.; Hembree, M.J.; Redenbaugh, E.P.; Radice, G.L.; Seidel, C.; Li, L. 2008: N-cadherin expression level distinguishes reserved versus primed states of hematopoietic stem cells. Cell Stem Cell 2(4): 367-379

Nieman, M.T.; Ethier, S.P.; Johnson, K.R.; Wheelock, M.J. 1998: N-cadherin expression promotes invasive phenotype in breast carcinoma cell lines. Proceedings of the American Association for Cancer Research Annual Meeting 39: 400

Li, J.; Levin, M.D.; Xiong, Y.; Petrenko, N.; Patel, V.V.; Radice, G.L. 2008: N-cadherin haploinsufficiency affects cardiac gap junctions and arrhythmic susceptibility. Journal of Molecular and Cellular Cardiology 44(3): 597-606

Beesley, P.W.; Mummery, R.; Tibaldi, J. 1994: N-cadherin is enriched in rat forebrain post synaptic density preparations. Society for Neuroscience Abstracts 20(1-2): 865

Ferreira Cornwell, M.C.; Grunwald, G.B.; Menko, A.S. 1995: N-cadherin plays a role in the differentiation of lens epithelial cells. Molecular Biology of the Cell 6(Suppl ): 171A

Hazan, R.B.; Kang, L.; Whooley, B.P.; Borgen, P.I. 1996: N-cadherin promotes adhesion between invasive breast cancer cell lines and the stroma. Molecular Biology of the Cell 7(Suppl ): 421A

Redfield, A.R.; Knudsen, K.A. 1996: N-cadherin promotes the differentiation of BHK cells into skeletal muscle. Molecular Biology of the Cell 7(Suppl ): 423A

George Weinstein, M.; Gerhart, J.; Reed, R.; Mattiacci, M.; Simak, E.; Steinberg, A.; Dawkins, S.; Knudsen, K. 1996: N-cadherin promotes the differentiation of chick embryo epiblast cells into skeletal muscle. Molecular Biology of the Cell 7(Suppl ): 40A

Perron, J.C.; Bixby, J.L. 1998: N-cadherin- and laminin-induced neurite outgrowth requires ERK signaling. Society for Neuroscience Abstracts 24(1-2): 1281

Hertig, C.; Eppenberger, M.; Butz, S.; Kemler, R.; Eppenberger, H.M. 1995: N-cadherin-catenin mediated cell contact in adult rat cardiomyocytes Truncated N-cadherin mutant impair cell contact and communication. Experientia 51(ABSTR ): A62

Linask, K.K.; Qui, Y.; Lee, H.Y.; Nagele, R.G. 1998: N-cadherin/beta-catenin interactions with microfilament bundles during neural tube formation in the chick. Molecular Biology of the Cell 9(Suppl ): 47A

Linask, K.K.; Yan, A.C.; Knudsen, K.A. 1996: N-cadherin/catenin complex involvement in early avian heart development. Molecular Biology of the Cell 7(Suppl ): 485A

Leblanc, L.; Borgford, T. 1995: N-cap mutants in the regulatory domain of chicken troponin-C. Biophysical Journal 68(2 Part 2): A58

Kim, W.H.; Lee, J.H.; Cho, H.S.; Kim, S.D.; Paik, W.K.; Kim, M.W. 1998: N-carbamoyl-L-glutamate plus L-arginine can protect ammonia intoxication in rats with cirrhosis. Hepatology 28(4 Part 2): 668A

Rana, A.; Siddiqui, N.; Khan, S.A.; Ehtaishamul Haque, S.; Bhat, M.A. 2008: N-{[(6-substituted-1,3-benzothiazole-2-yl)amino]carbonothioyl}-2/4-substituted benzamides: synthesis and pharmacological evaluation. European Journal of Medicinal Chemistry 43(5): 1114-1122

Hussain, A.A.; Tashtoush, B.; Dittert, L.W. 1998: N-chloro-N-methyl glucamine and N-chloro-N-methyl glucamine esters as novel safe agents for water disinfection. Official Gazette of the United States Patent and Trademark Office Patents 1210(3): 2631

Tashtoush, B.; Kao, H.D.; Hussain, A.A. 1995: N-chloro-N-methylglucamine A potentially useful water disinfectant I Chemistry. Pharmaceutical Research (New York) 12(9 Suppl): S323

Cho, E.H.; Chung, S.G.; Lee, K.H.; Park, S.K. 1998: N-cinnamoyl-2-methyl-5-methoxy-3-indoleacetic acid ester, and pharmaceutical preparation containing the same. Official Gazette of the United States Patent and Trademark Office Patents 1210(1): 524

Shah, J.H.; Izenwasser, S.; Witkin, J.M.; Geter Douglass, B.; Newman, A.H. 1995: N-cinnamyl benzazepine analogs are potent and selective dopamine-D-1 receptor ligands. Abstracts of Papers American Chemical Society 209(1-2): MEDI 85

Furuta, H.; Asano, T.; Ogawa, T. 1994: N-confused porphyrin A new isomer of tetraphenylporphyrin. Journal of the American Chemical Society 116(2): 767-768

Bramm, E.; Petersen, H.J. 1996: N-cyano-N-pyridylguanidines as serotonin antagonists. Official Gazette of the United States Patent and Trademark Office Patents 1191(2): 1121

Andree, R.; Drewes, M W.; Marhold, A.; Santel, H J.; Dollinger, M. 1997: N-cyanoaryl-nitrogen heterocycles. Official Gazette of the United States Patent and Trademark Office Patents 1194(2): 1215-1216

Haase, J.; Kuhn, M. 1998: N-cyanomethylated chitosans and hydrolysates thereof. Official Gazette of the United States Patent and Trademark Office Patents 1209(3): 2353

Hsu, K H.L.; Teller, D.M.; Davis, A.R.; Lubeck, M.D.; Munson, H.R.Jr; Jagdmann, G.E.; Uwaydah, I.M. 1996: N-cyanomidine derivatives as anti-influenza agents. Official Gazette of the United States Patent and Trademark Office Patents 1186(3): 2029

Evans, C.A.; Miller, E.K.; Friedland, A.J. 1996: N-cycling rates in high elevation spruce fir forests The effects of community heterogeneity. Bulletin of the Ecological Society of America 77(3 Suppl Part 2): 132

Eicken, K.; Ammermann, E.; Lorenz, G. 1995: N-cyclohex yl-pyridine carboxamides and compositions containing them for controlling fungal pests. Official Gazette of the United States Patent and Trademark Office Patents 1174(3): 1923

Oturai, P.S.; Rolin, B.; Jensen, T.; Kofoed Enevoldsen, A. 1996: N-deacetylase mRNA expression in diabetic rats. Diabetologia 39(Suppl 1): A309

Pogell, B.M. 1993: N-dealkylation and complete degradation of atrazine by microorganisms. Baltz, R H, Hegeman, G D, Skatrud, P P Industrial microorganisms: Basic and applied molecular genetics: 284

Wilkins, L.H.; Pauly, J.R.; Crooks, P.A.; Dwoskin, L.P. 1997: N-decylnicotinium iodide inhibits nicotine-evoked 86Rubidium+ efflux from rat striatal synaptosomes. Society for Neuroscience Abstracts 23(1-2): 1198

Schmider, J.; Greenblatt, D.J.; Von Moltke, L.L.; Shader, R.I. 1995: N-demethylation of amitriptyline in vitro Role of CYP3A isoforms. Clinical Pharmacology and Therapeutics 57(2): 193

Christ, W.; Hecker, W.; Christ, H.; Kemmler, H. 1994: N-demethylation of chlorpromazine , imipramine , tilidine and diazepam by microsomes of small intestine from guinea pig. Naunyn-Schmiedeberg's Archives of Pharmacology 349(Suppl): R4

ChenTing; DaiYiJun; DingJuanFang; YuanSheng; NiJuePing 2008: N-demethylation of neonicotinoid insecticide acetamiprid by bacterium Stenotrophomonas maltophilia CGMCC 11788. Biodegradation: 5, 651-658. Ef

Sinniger, V.; Chovet, M.; Lamy, C.; Fournet, J.; Feuerstein, C.; Bonaz, B. 1998: N-desmethyl-trimebutine prevents visceral pain-induced c-Fos expression in the rat spinal cord. Society for Neuroscience Abstracts 24(1-2): 381

Bergijk, E.C.; Van Alderwegen, I.E.; Sutmuller, M.; Baelde, J.J.; And, E.D.H.er; Bruijn, J.A. 1995: N-desulfated heparinoids prevent the development of glomerulosclerosis in experimental lupus nephritis. Journal of the American Society of Nephrology 6(3): 892

Weber, B.; Riess, O.; Daneshvar, H.; Graham, R.; Hayden, M.R. 1993: N-dinucleotide repeat at the PDEB locus in 4p163. Human Molecular Genetics 2(6): 827

Riess, O.; Weber, B.; Hayden, M.R. 1992: N-dinucleotide repeat polymorphism at the locus for the alpha2C adrenergic receptor on 4p16. Human Molecular Genetics 1(6): 452

Katz, D.H.; Pope, L.E.; Marcelletti, J.F.; Khalil, M.H.; Katz, L.R. 1994: N-docosanol A new broad spectrum anti-viral drug. Clinical Research 42(2): 300A

Bunke, A.; Jira, T.; Beyrich, T. 1997: N-dodecyl-N-methylephedrinium bromide as chiral selector in capillary electrophoresis. Pharmazie 52(10): 762-764

Badoud, R.; Fay, L. 1995: N-epsilon-carboxymethyllysine and N-carboxymethyl amino acids as indicators of the early Maillard reaction. Abstracts of Papers American Chemical Society 210(1-2): AGFD 102

Puri, R.N.; Colman, R.W. 1996: N-ethyl-5-phenylisooxazolium-3-sulfonate inhibits ADP-induced platelet responses by inhibiting binding of ADP to aggregin, an ADP receptor. FASEB Journal 10(6): A1099

Goh, L.B.; Tu, Y.H.; Lee, C.W. 1994: N-ethylmaleimide A possible covalent label for NBMPR-insensitive nucleoside transport of murine myeloma cells. Proceedings of the American Association for Cancer Research Annual Meeting 35: 576

Bellingham, M.C.; Walmsley, B. 1998: N-ethylmaleimide alters evoked quantal transmitter release asynchrony and enhances spontaneous quantal release frequency. Society for Neuroscience Abstracts 24(1-2): 1315

Phelan, K.D.; Mahler, H.R. 1996: N-ethylmaleimide alters the intrinsic membrane properties and inhibitory synaptic potentials of neurons in a rat septal slice preparation. Society for Neuroscience Abstracts 22(1-3): 811

Alger, B.E.; Pitler, T.A.; Wagner, J.J. 1995: N-ethylmaleimide blocks depolarization-induced suppression of inhibition in rat hippocampal pyramidal cells. Society for Neuroscience Abstracts 21(1-3): 1093

Wenge, B.; Bönisch, H. 2008: N-Ethylmaleimide differentially inhibits substrate uptake by and ligand binding to the noradrenaline transporter. Naunyn-Schmiedeberg's Archives of Pharmacology 377(3): 255-265

Alexander, S.P.H.; Curtis, A.R.; Kendall, D.A. 1994: N-ethylmaleimide effects on adenosine receptor function in the guinea-pig cerebral cortex. British Journal of Pharmacology 111(Proceedings Suppl JAN ): 258P

Lauf, P.K.; Moezzi, R.; Adragna, N.C. 1994: N-ethylmaleimide treatment of low K sheep red blood cells at different temperatures reveals role of thiols and Mg for activation and inactivation of K-Cl cotransport. Biophysical Journal 66(2 Part 2): A32

Subramaniam, V.N.; Loh, E.; Hong, W. 1997: N-ethylmaleimide-sensitive factor and alpha-soluble NSF attachment proteins mediate dissociation of GS28-syntaxin 5 Golgi SNAP receptors complex. Journal of Biological Chemistry 272(41): 25441-25444

Katano, T.; Furue, H.; Okuda-Ashitaka, E.; Tagaya, M.; Watanabe, M.; Yoshimura, M.; Ito, S. 2008: N-ethylmaleimide-sensitive fusion protein (NSF) is involved in central sensitization in the spinal cord through GluR2 subunit composition switch after inflammation. European Journal of Neuroscience 27(12): 3161-3170

Angelico, M.; Mangiameli, A.; Nistri, A.; Sofia, M.; Di Martino, M.; Maina, M.; Baiocchi, L.; Blasi, A. 1994: N-ethyltauroursodeoxycholic acid, a novel bile salt analogue resistant to bacterial deconjugation Effect of chronic gastric feeding in the rat. Gastroenterology 106(4 Suppl): A860

Sulieman,S.; Fischinger,S.; Schulze,J. 2008: N-feedback regulation of N2 fixation in Medicago truncatula under P-deficiency. General And Applied Plant Physiology: 1 2, 33-54

Ying, W.; Desmarteau, D.D.; Gotoh, Y. 1996: N-fluoro-bis sulfonyl Imide Electrophilic fluorination of imines and some methyl-substituted pyridines. Tetrahedron 52(1): 15-22

Prossnitz, E.R. 1997: N-formyl peptide receptor phosphorylation is required for internalization and desensitization but not chemotaxis. Molecular Biology of the Cell 8(Suppl ): 383A

Baker, C.S.; Goijburg, D.L.; Phillips, A.T. 1997: N-formylglutamate amidohydrolase from Pseudomonas putida Sequence and properties. Abstracts of the General Meeting of the American Society for Microbiology 97: 370

Prossnitz, E.R.; Schreiber, R.E.; Bokoch, G.M.; Cochrane, C.G.; Ye, R.D. 1992: N-formylpeptide receptor domains involved in receptor-G protein interactions. Journal of Leukocyte Biology 1992(Suppl 3): 50

Hodson, H.F. 1998: N-g-monomethyl-L-arginine hydrochloride derivatives and their use in the treatment of septic shock. Official Gazette of the United States Patent and Trademark Office Patents 1211(3): 2985

Schupke, H.; Bauer, C.; Mcneilly, P.J.; Hempel, R.; Strong, J.; Kupferberg, H.J.; Kronbach, T. 1996: N-glucuronidation as a major metabolic pathway of the new anticonvulsant D-23129 in rats, dogs and man. Naunyn-Schmiedeberg's Archives of Pharmacology 354(4 Suppl 1: R43

Babu, S.; Lakshimi, V.; Kane, R.; Hsu, F.; Zenser, T.; Davis, B. 1993: N-glucuronidation of benzidine by human liver. Proceedings of the American Association for Cancer Research Annual Meeting 34: 163

Mackiewicz, A.; Khan, M.A.; Calabrese, L.; Espinoza, L.R. 1992: N-glycan microheterogeneity of alpha-1-acid glycoprotein in HIV infected patients with and without arthritis. Arthritis and Rheumatism 35(9 Suppl): S86

Takahashi, M.; Yokoe, S.; Asahi, M.; Lee, S.H.; Li, W.; Osumi, D.; Miyoshi, E.; Taniguchi, N. 2008: N-glycan of ErbB family plays a crucial role in dimer formation and tumor promotion. Biochimica et Biophysica Acta 1780(3): 520-524

Ruddock, L.W.; Molinari, M. 2006: N-glycan processing in ER quality control. Journal of Cell Science 119(Part 21): 4373-4380

Xie, W.; Gender, S.J. 1996: N-glycans direct the apical expression of the epithelial mucin MUC1 in cells. Molecular Biology of the Cell 7(Suppl ): 77A

Lige, B.; Van Huystee, R.B. 1997: N-glycosylated analysis of the cationic peanut peroxidase expressed in transgenic tobacco plants. Plant Physiology (Rockville) 114(3 Suppl): 299

Lerouge, P.; Fitchette Laine, A.C.; Cabanes, M.; Ma, J.; Faye, L. 1996: N-glycosylation analysis of a mouse monoclonal antibody expressed in transgenic tobacco plants. Plant Physiology (Rockville) 111(2 Suppl): 168

He, Y.; Ramsay, A.J.; Hunt, M.L.; Whitbread, A.K.; Myers, S.A.; Hooper, J.D. 2008: N-glycosylation analysis of the human Tweety family of putative chloride ion channels supports a penta-spanning membrane arrangement: impact of N-glycosylation on cellular processing of Tweety homologue 2 (TTYH2). Biochemical Journal 412(1): 45-55

Martinez, J.A.; Banerjee, D.K. 1998: N-glycosylation inhibition on endothelial cell proliferation and viability. FASEB Journal 12(8): A1350

Maciewicz, R.A.; Van Der Stappen, J.W.J.; Paraskeva, C. 1994: N-glycosylation of cysteine proteinase inhibitors A possible control mechanism for the determination of malignant potential. Journal of Cellular Biochemistry Suppl 1994(18D): 145

Gehle, V.M.; Sumikawa, K. 1992: N-glycosylation of nicotinic acetylcholine receptor subunits is required for efficient intracellular transport of assembled receptors. Society for Neuroscience Abstracts 18(1-2): 437

Kedzierski, W.; Bok, D.; Travis, G.H. 1997: N-glycosylation of rds/peripherin Role in protein processing and the formation of photoreceptor outer segments. IOVS Investigative Ophthalmology and Visual Science 38(4 Part 1-2): S1165

Huang, L.; Fu, D.; Spellman, M.W.; Van Halbeek, H. 1992: N-glycosylation site mapping of recombinant HIV-1 envelope glycoprotein-120 expressed in CHO cells. Glycobiology 2(5): 473

Schwalbe, R.A.; Wang, Z.; Brown, A.M. 1996: N-glycosylation studies of ROMK1 reveal unexpected extracellular regions in the pore-forming segment. Biophysical Journal 70(2 Part 2): A309

Schwalbe, R.A.; Bianchi, L.; Brown, A.M. 1997: N-glycosylation tags and K+ selectivity in ROMK1. Biophysical Journal 72(2 Part 2): A254

Wu, Y.Q.; Wilkinson, D.; Soni, R.; Scott, C.; Ross, D.T.; Guo, H.; Howorth, P.; Chen, Y.; Valentine, H.; Liang, S.; Spicer, D.; Steiner, J.; Hamilton, G. 1998: N-glyoxyl prolyl and pipecolyl amide FKBP12 ligands Potent neurotrophic agents in an animal model of Parkinsons disease. Abstracts of Papers American Chemical Society 216(1-3): MEDI 103

Schueytze, R.; Kehne, H.; Bauer, K.; Bieringer, H. 1998: N-heteroartyl-N- ureas, processes for their preparation, and their use as herbicides and plant growth regulators. Official Gazette of the United States Patent and Trademark Office Patents 1217(2): 1669-1670

Strupczewski, J.T.; Glamkowski, E.J. 1996: N-heteroaryl-1-pyrrolidinylalkyl-2-benoxazolinones and related compounds and their therapeutic utility. Official Gazette of the United States Patent and Trademark Office Patents 1193(1): 463

Haaf, K.; Kehne, H.; Bauer, K.; Bieringer, H. 1998: N-heteroaryl-N- ureas, processes for their preparation, and their use as herbicides and plant growth regulators. Official Gazette of the United States Patent and Trademark Office Patents 1207(1): 435-436

Agback, H.; Ahrgren, L.; Berglindh, T.; Haraldsson, M.; Smedegard, G.; Olsson, L I. 1996: N-heterocyclic substituted salicylic acids. Official Gazette of the United States Patent and Trademark Office Patents 1190(3): 2070

Phillips, P.J.; Ballard, P.G.; Bradbury, R.H.; James, R. 1997: N-heterocyclic sulfonamides having endothelin receptor activity. Official Gazette of the United States Patent and Trademark Office Patents 1202(3): 2233-2234

Baudy, R.B.; Berta, S.C. 1997: N-heterocycloalkyl carboxamides as serotonergic agents. Official Gazette of the United States Patent and Trademark Office Patents 1195(2): 1206

Easaw, P.E.S. 1997: N-hexane neuropathy as an occupational disease A clinical and neurophysiological study of four cases. Journal of the Neurological Sciences 150(Suppl ): S64

Bhattarai, S.R.; Kc, R.B.; Kim, S.Y.; Sharma, M.; Khil, M.S.; Hwang, P.H.; Chung, G.H.; Kim, H.Y. 2008: N-hexanoyl chitosan stabilized magnetic nanoparticles: Implication for cellular labeling and magnetic resonance imaging. Journal of Nanobiotechnology 6: 1

Pushkareva, M.Y.; Janoff, A.S. 1996: N-hexanoyl- and N-hexyl sphingosine differentially effect mitochondrial membrane potential changes leading to apoptosis. Molecular Biology of the Cell 7(Suppl ): 348A

Theodorakis, E.A.; Wilcoxen, K.M. 1996: N-hydroxy-2-thiopyridone and derivatives as generators of oxygen radicals Design of new DNA-photocleaving reagents. Abstracts of Papers American Chemical Society 211(1-2): ORGN 135

Allen, R.C.; Helsley, G.C.; Hamer, R.R.; Freed, B.S.; White, J.L.; Martin, L.L. 1998: N-hydroxy-dibenz oxepinalkylamines, N-hydroxy-dibenz oxepinalkanoic acid amides and related heterocyclic analogues. Official Gazette of the United States Patent and Trademark Office Patents 121(4): 4026

Harsanyi, K.; Gizur, T.; Agai Csongor, E.; Kallai Sohonyai, A.; Kapolnas Pap, M.; Csizer, E.; Hegedus, B.; Szporny, L.; Kiss, B.; Karpati, E.; Palosi, E.; Szombathelyi, Z.; Sarkadi, A.; Gere, A.; Bodo, M.; Csomor, K.; Laszy, J.; Szentirmai, Z.; Lapis, E.; Szabo, S. 1996: N-hydroxyalkyl-substituted 1,2,3,6-tetrahydro-pyridine and piperidine derivatives. Official Gazette of the United States Patent and Trademark Office Patents 1193(5): 3581

Ohkanda, J.; Katoh, A. 1995: N-hydroxyamide-containing heterocycles Part 5 Synthesis of novel hexadentate ligands composed of N-hydroxy-2 -pyrazinone, aliphatic diamine, and 1,1,1-tris ethane, and properties of their ferric complexes. Tetrahedron 51(47): 12995-13002

Watanabe, M.; Igarashi, T.; Kaminuma, T.; Sofuni, T.; Nohmi, T. 1994: N-hydroxyarylamine O-acetyltransferase of Salmonella typhimurium: proposal for a common catalytic mechanism of arylamine acetyltransferase enzymes. Environmental Health Perspectives 102(Suppl 6): 83-89

Landi, M.T.; Bertazzi, P.A.; Caporaso, N.E.; Kadlubar, F.F.; Tannembaum, S.; Skipper, P.; Vineis, P. 1995: N-hydroxylation and hemoglobin adducts. Proceedings of the American Association for Cancer Research Annual Meeting 36: 283

Ando, K.; Ikeda, T. 1995: N-hydroxyurea derivatives which inhibit lipoxygenase. Official Gazette of the United States Patent and Trademark Office Patents 1170(4): 2504-2505

Malamas, M.S.; Nelson, J.A. 1995: N-hydroxyureas as 5-lipoxygenase inhibitors and inhibitors of oxidative modification of low density lipoprotein. Official Gazette of the United States Patent and Trademark Office Patents 1179(3): 1830

Ando, A.; Stevens, R.W. 1998: N-hydroxyureas as antiinflammatory agents. Official Gazette of the United States Patent and Trademark Office Patents 1214(5): 5339

Nishiuchi, Y.ji; Nishio, Hideki; Inui, Tatsuya; Kimura, Terutoshi; Sakakibara, Shumpei 1996: N-in-cyclohexyloxycarbonyl group as a new protecting group for tryptophan. Tetrahedron Letters 37(42): 7529-7532

Katerinopoulos, H.E.; Tagmatarchis, N.; Thermos, K. 1997: N-iodopropenyl-octahydrobenzo - and - quinoline analogs with adrenergic and dopaminergic activity. Abstracts of Papers American Chemical Society 214(1-2): MEDI 21

Tokaji, Z.; Der, A. 1996: N-like intermediate of the photocycle of acid purple form of bacteriorhodopsin. Progress in Biophysics and Molecular Biology 65(Suppl 1): 165

Shakin Eshleman, S.; Kasturi, L.; Clute, J. 1996: N-linked core-glycosylation efficiency is influenced by the X and hydroxy amino acids in ASN-X-SER/THR sequons. FASEB Journal 10(6): A1369

Garrity, R.; Minassian, A.; Rimmelzwaan, G.; Tsai, W.P.; Dunlop, N.; Conley, S.; Goudsmit, J.; Nara, P. 1994: N-linked epitope masking results in shift in neutralizing response away from V3 to V1. AIDS Research and Human Retroviruses 10(Suppl 3): S134

Trimble, R.B.; Verostek, M. 1993: N-linked glycan modeling in yeast Control through sugar transferase substrate specificity or by the cellular subcompartmentation of processing enzymes?. Glycobiology 3(5): 515

Burda, Patricie; Te Heesen, Stephen; Aebi, Markus 1996: N-linked glycosylation ALG9 and ALG10, two new loci involved in the biosynthesis of dolichol-linked oligosaccharides in Saccharomyces cerevisiae. Molecular Biology of the Cell 7(Suppl ): 132A

Chakraborty, A.K.; Sodi, S.A.; Orlow, S.J.; Rosemblat, S.; Keh Yen, A.; Bolognia, J.; Rachkovsky, M.L.; Pawelek, J. 1998: N-linked glycosylation as a regulator of phenotypic expression in melanoma x macrophage fusion hybrids. Proceedings of the American Association for Cancer Research Annual Meeting 39: 496

Zufferey, R.; Reiss, G.; Burda, P.; Te Heesen, S.; Aebi, M. 1995: N-linked glycosylation in yeast The essential gene SLW1 is required for the transfer of the core oligosaccharide to asparagine residues in vivo. Experientia 51(ABSTR ): A74

Karpa, K.D.; Bergson, C.; Levenson, R. 1998: N-linked glycosylation is essential for plasma membrane localization of human D5 dopamine. Society for Neuroscience Abstracts 24(1-2): 1360

Vukmirica, J.; Nishimaki Mogami, T.; Mcleod, R.S.; Yao, Z. 1998: N-linked glycosylation is important for posttranslational stability and efficient secretion of apo-B. Molecular Biology of the Cell 9(Suppl ): 346A

Davis, D.P.; Liu, X.; Segaloff, D.L. 1995: N-linked glycosylation is required for functional maturation of the FSH and the LH/CG receptors. FASEB Journal 9(6): A1249

Hair, G.A.; Schmeizl, M.; Distasio, D.; Zeff, R.; Rickles, F.R. 1994: N-linked glycosylation is required for membrane expression of cellular tissue factor. Clinical Research 42(2): 183A

Kolhekar, A.S.; Quon, A.S.W.; Berard, C.A.; Mains, R.E.; Eipper, B.A. 1997: N-linked glycosylation occurs posttranslationally during the biosynthesis of a secretory granule enzyme. Molecular Biology of the Cell 8(Suppl ): 310A

Aebi, M.; Te Heesen, S.; Stagljar, I.; Zufferey, R.; Reiss, G.; Burda, P. 1995: N-linked glycosylation of proteins in the endoplasmic reticulum of Saccharomyces cerevisiae. Experientia 51(ABSTR ): A51

Khan, M.W.; Musgrave, S.C.; Jenkins, N. 1995: N-linked glycosylation of tissue plasminogen activator in Namalwa cells. Biochemical Society Transactions 23(1): 99s

Martayan, A.; Sibilio, L.; Setini, A.; Lo Monaco, E.; Tremante, E.; Fruci, D.; Colonna, M.; Giacomini, P. 2008: N-linked glycosylation selectively regulates the generic folding of HLA-Cw1. Journal of Biological Chemistry 283(24): 16469-16476

Yang, B.; Hoe, M.H.; Hunt, R.C. 1993: N-linked oligosaccharide at ASN727 of human transferrin receptor is required for exiting the endoplasmic reticulum when disulphide bridges of the receptor are interrupted by dithreitol. Molecular Biology of the Cell 4(Suppl ): 87A

Hounsell, E.F.; Davies, M.J.; Smith, K.D. 1996: N-linked oligosaccharide profiling by HPAEC-PAD. Walker, J M The protein protocols handbook 661-662

Hounsell, E.F.; Davies, M.J.; Smith, K.D. 1996: N-linked oligosaccharide profiling by HPLC on porous graphitized carbon. Walker, J M The protein protocols handbook 659-660

Bernardo, R.R.; Palatnik, D.S.usa, C.B.; Parente, J.P. 1997: N-linked oligosaccharide structures of the FML antigen of Leishmania donovani. Memorias do Instituto Oswaldo Cruz 92(Suppl 1): 146

Bjorklund, J.E.M.; Karlsson, T.; Magnusson, C.G.M. 1998: N-linked oligosaccharides influence the epitope expression of human myeloma IgE. Allergy 53(Suppl 43): 14

Steltenkamp, R.J. 1995: N-lower alkyl neoalkanamide insect repellents. Official Gazette of the United States Patent and Trademark Office Patents 1171(3): 1805

Zavanella,M.; Barbanti,L.; Venturi,G. 2008: N-management in beet with Nib software. Informatore Agrario: 44, 36-39

Fournie Zaluski, M C.; Roques, B P. 1997: N-mercaptoacyl compounds and S-lipophiic aliphatic carbonyl derivatives thereof as antihypertensives. Official Gazette of the United States Patent and Trademark Office Patents 1194(1): 495

Bidlack, J.M.; Kaplan, R.A.; Sebastian, A.; Seyed Mozaffari, A.; Hutchinson, I.; Archer, S. 1995: N-methyl and N-cyclopropylmethyl-14-alpha,14beta- iminobis. Bioorganic and Medicinal Chemistry Letters 5(15): 1695-1700

Lavergne, J.A.; Albina, J.E.; Saavedra, S.; Del Llano, A.M. 1995: N-methyl mono L-arginine, a nitric oxide inhibitor, reduces apoptosis in cultured PBLs from HIV+ patients. FASEB Journal 9(3): A528

Naoi, M.; Maruyama, W. 1996: N-methyl salsolinol as a candidate neurotoxin to induce Parkinsons disease. Society for Neuroscience Abstracts 22(1-3): 222

Patt, J.T.; Westera, G.; Buck, A.; Fletcher, S.R.; Shubiger, P.A. 1995: N-methyl- and fluoroethylepibatidine Ligands for the neuronal nicotinic receptor. Journal of Labelled Compounds and Radiopharmaceuticals 37: 355-356

Arai, M.; Minatoguchi, S.; Takemura, G.; Uno, Y.; Kariya, T.; Fujiwara, T.; Higashioka, M.; Yoshikuni, Y.; Fujiwara, H. 1997: N-methyl-1-deoxynojirimycin, an alpha-glucosidase inhibitor, reduces markedly infarct size in rabbit hearts. Journal of the American College of Cardiology 29(2 Suppl A): 266A-267A

Cavero, I.; Mondot, S. 1995: N-methyl-2- -tetrahydrothio-pyran-2-carbothioamide 1-oxide to the preparation of medicinal products intended for treatment of coronary insufficiency. Official Gazette of the United States Patent and Trademark Office Patents 1175(3): 1804-1805

Mortlock, A.A.; Bath, C.; Butlin, R.J.; Heys, C.; Hunt, S.J.; Reid, A.C.; Sumner, N.F.; Tang, E.K.; Whiting, E.; Wilson, C.; Wright, N.D. 1997: N-methyl-2- phenyl-3-. Bioorganic and Medicinal Chemistry Letters 7(11): 1399-1402

Kassiou, M.; Katsifis, A.; Lambrecht, R.M.; Eu, P.; Hicks, R. 1994: N-methyl-4-iododexetimide A radioiodinated ligand for SPECT studies of myocardial muscarinic receptors. Journal of Labelled Compounds and Radiopharmaceuticals 35: 232-233

Snyder, S.E.; Bormans, G.; Sherman, P.; Kuhl, D.E.; Kilbourn, M.R. 1995: N-methyl-4-piperidinol esters as in vivo substrates for acetylcholinesterase. Journal of Nuclear Medicine 36(5 Suppl): 58P-59P

Ehrlich, P.P.; Didomenico, S.; Lin, C.W.; Bianchi, B.; Stashko, M.; Britton, D.R.; Mikusa, J.; Mahan, L.; Asin, K.; Hodges, L.; Nikkel, A.; Miller, T.; Roberts, E. 1995: N-methyl-5- -phenylhexahydrobenz isoquinoline A novel lead for the development of potent and selective DA D-1 receptor agonists. Abstracts of Papers American Chemical Society 209(1-2): MEDI 72

Rayevsky, K.; Bashkatova, V.; Vitskova, G.; Narkevich, V.; Mikoyan, V.; Vanin, A. 1997: N-methyl-D,L-aspartate dramatically increases nitric oxide content in the rat brain cortex. Journal of Neurochemistry 69(Suppl ): S112

Estienne, M.J.; Hartsock, T.G.; Harter Dennis, J.M.; Barb, C.R. 1993: N-methyl-D,L-aspartate increases concentrations of LH and growth hormone in serum of prepubertal gilts. Journal of Animal Science 71(Suppl 1): 206

Kim, Y.I.; Chandler, S.H. 1993: N-methyl-D,L-aspartate induced voltage oscillations in guinea pig trigeminal motoneurons recorded in vitro. Society for Neuroscience Abstracts 19(1-3): 985

Wu, P.H.; Liu, J.F.; Lanca, A.J.; Arifuzzaman, A.I.; Grupp, L.; Kalant, H. 1995: N-methyl-D-aspartate -induced septal lesion prevents the retention of tolerance to ethanol by desglycinamide-9- -vasopressin. Society for Neuroscience Abstracts 21(1-3): 1339

Beckstead, R.M. 1995: N-methyl-D-aspartate acutely increases proenkephalin mRNA in the rat striatum. Synapse 21(4): 342-347

Spangler, E.; Ingram, D.K.; Kametani, H. 1996: N-methyl-D-aspartate administration in rat hippocampus and striatum increases nitrite and nitrate levels A measure of nitric oxide release. Society for Neuroscience Abstracts 22(1-3): 1532

Sandkuehler, J.; Liu, X.G.; Zimmermann, M. 1995: N-methyl-D-aspartate and neurokinin receptors are critical for the induction of long-term potentiation of C-fiber evoked field potentials in rat spinal dorsal horn. Society for Neuroscience Abstracts 21(1-3): 1641

Neugebauer, V.; Luecke, T.; Schaible, H.G. 1993: N-methyl-D-aspartate and non-NMDA receptor antagonists block the hyperexcitability of dorsal horn neurons during development of acute arthritis in rats knee joint. Journal of Neurophysiology (Bethesda) 70(4): 1365-1377

Xu, X.; Domino, E.F. 1993: N-methyl-D-aspartate antagonist MK-801 blocks amphetamine induced but not phencyclidine induced behavioral sensitization. Society for Neuroscience Abstracts 19(1-3): 1012

Lam, T.T.; Fu, J.; Li, S.H.; Abler, A.S.; Tso, M.O.M. 1995: N-methyl-D-aspartate induced apoptosis in rat retina. IOVS Investigative Ophthalmology and Visual Science 36(4): S934

Kodama, T.; Honda, Y.; Watanabe, M. 1995: N-methyl-D-aspartate induced cyclic-GMP release as an index of nitric oxide in the laterodorsal tegmental nucleus. Society for Neuroscience Abstracts 21(1-3): 624

Kwong, M.K.; Lam, T.T. 1997: N-methyl-D-aspartate induced delayed cell death in adult rabbit retina. IOVS Investigative Ophthalmology and Visual Science 38(4 Part 1-2): S101

Zapata, A.; Capdevila, J.L.; Trullas, R. 1997: N-methyl-D-aspartate induces a calcium dependent and region specific increase in extracellular choline levels. Journal of Neurochemistry 69(Suppl ): S76

Shin, C.; Colberg, M.; Sun, X. 1994: N-methyl-D-aspartate induces expression of c-fos mRNA in explant culture of rat hippocampus. Epilepsia 35(Suppl 8): 65

Smyth, C.; Wilkinson, D.; Wilkinson, M. 1996: N-methyl-D-aspartate induces heat shock protein-like immunoreactivity in the hypothalamus of prepubertal female rats. Journal of Physiology (Cambridge) 491P: 179P-180P

Shin, C.; Sun, X.; Colberg, M. 1994: N-methyl-D-aspartate induces the expression of c-fos mRNA in the organotypic culture of rat hippocampus. Society for Neuroscience Abstracts 20(1-2): 613

Landeira Fernandez, J.; Grijalva, C.V. 1993: N-methyl-D-aspartate lesions in the substantia nigra but not in the ventral tegmental area produces gastric erosions in the rat. Society for Neuroscience Abstracts 19(1-3): 959

Pullan, L.M.; Asiedu, S.; Britt, M.; Siddigui, K.; Slusher, B.; Stumpo, R.J. 1994: N-methyl-D-aspartate lesions may create a penumbra of inflammation similar to focal ischemia. Society for Neuroscience Abstracts 20(1-2): 612

Haji, A.; Ohi, Y.; Tsunekawa, S. 2008: N-methyl-D-aspartate mechanisms in depolarization of augmenting expiratory neurons during the expulsive phase of fictive cough in decerebrate cats. Neuropharmacology 54(7): 1120-1127

Lee, K.; Wilson, R.A.; Ross, J.L.; Shin, C. 1996: N-methyl-D-aspartate mediated excitotoxicity induces delayed neuronal death through apoptosis in organotypic culture of rat hippocampus. Epilepsia 37(Suppl 5): 40

Pantazis, N.J.; Dohrman, D.P.; Goodlett, C.R.; West, J.R. 1993: N-methyl-D-aspartate prevents alcohol-induced depletion of cerebellar granule cells in culture. Alcoholism Clinical and Experimental Research 17(2): 453

Allen, R.M.; Tiano, M.J.; Dykstra, L.A. 1998: N-methyl-D-aspartate receptor antagonists potentiate the effects of morphine in a primate model of antinociception. Society for Neuroscience Abstracts 24(1-2): 1868

Mickley, G.A.; Balogh, S.A.; Neimanis, K.; Goulis, P.; Hug, J.; Sauchak, K.; Yamamoto, B.K. 1996: N-methyl-D-aspartate receptor blockade differentially modulates fetal and neonatal conditioned taste aversions Brain ketamine content. Society for Neuroscience Abstracts 22(1-3): 142

Hohimer, A.R.; Bissonnette, J.M.; Knopp, S.J. 1994: N-methyl-D-aspartate receptor blockade increases the depth of fetal breathing movements. FASEB Journal 8(4-5): A909

Hallak, M.; Hotra, J.W.; Anthony, M.J.; Svinarich, D.M. 1998: N-methyl-D-aspartate receptor gene transcription in fetal rat brain Effect of magnesium sulfate. American Journal of Obstetrics and Gynecology 178(1 Part 2): S39

Schwartz, M.; Muler, S.; Belkin, M.; Yoles, E. 1996: N-methyl-D-aspartate receptor is involved in the secondary degeneration induced by optic nerve lesions. IOVS Investigative Ophthalmology and Visual Science 37(3): S493

Mize, R.R.; Butler, G.D. 1995: N-methyl-D-aspartate receptor localization, identified using antibody immunocytochemistry, is primarily postsynaptic in the cat superior colliculus. Society for Neuroscience Abstracts 21(1-3): 1618

Yamamoto, H.; Akama, K.; Kersey, D.; Moskal, J. 1993: N-methyl-D-aspartate receptor mRNA expression in NG108-15 cells undergoing synapse formation. Society for Neuroscience Abstracts 19(1-3): 1357

Nakajima, J.; Kowk, K.; Baimbridge, K.; Kani, K. 1997: N-methyl-D-aspartate receptor mediated calcium accumulation in rat retinal ganglion cells. IOVS Investigative Ophthalmology and Visual Science 38(4 Part 1-2): S607

Brodsky, M.; Elliott, K.; Warwick, B.; Inturrisi, C.E. 1995: N-methyl-D-aspartate receptor splice variants differ in selected regions of rat CNS. Society for Neuroscience Abstracts 21(1-3): 1836

Shinno, H.; Mikuni, M.; Saitoh, K.; Yamawaki, S.; Takahashi, K. 1993: N-methyl-D-aspartate receptor-like complex is coupled to pertussis toxin-sensitive G-protein and phospholipase C in C6 cell. Society for Neuroscience Abstracts 19(1-3): 1781

Li, J.; Baltas, L.; Huang, K.P.; Huang, F.L. 1998: N-methyl-D-aspartate receptor-mediated oxidation and phosphorylation of neurogranin/RC3 and neuromodulin/GAP43 in rat brain slices. Society for Neuroscience Abstracts 24(1-2): 863

Hochman, S.; Jordan, L.M.; MacDonald, J.F. 1994: N-methyl-D-aspartate receptor-mediated voltage oscillations in neurons surrounding the central canal in slices of rat spinal cord. Journal of Neurophysiology 72(2): 565-577

Binns, K.E.; Salt, T.E. 1995: N-methyl-D-aspartate receptors and cortical influences on visual responses in the superior colliculus of the anaesthetized cat. Journal of Physiology (Cambridge) 485P: 11P-12P

Borkowska, H.D.; Oja, S.S.; Albrecht, I.; Saransaari, P. 1995: N-methyl-D-aspartate receptors and dopamine release in experimental hepatic encephalopathy. Acta Neurobiologiae Experimentalis 55(Suppl ): 51

Hagberg, H.; Andine, P.; Puka, M.; Lazarewicz, J.; Gadamski, R. 1993: N-methyl-D-aspartate receptors and extracellular calcium changes during ischemia in the newborn and adult brain in vivo. Society for Neuroscience Abstracts 19(1-3): 1641

Alesiani, M.; Moroni, F. 1993: N-methyl-D-aspartate receptors are present in the myenteric plexus. Digestive Diseases and Sciences 38(4): 777

Manis, P.B.; Molitor, S.C. 1996: N-methyl-D-aspartate receptors at parallel fiber synapses in the dorsal cochlear nucleus. Journal of Neurophysiology 76(3): 1639-1656

Gillis, R.A.; Henandez, Y.M.; Bingaman, M.; Panico, W.; Silva, A.T.veira Da 1997: N-methyl-D-aspartate receptors at the ventrolateral nucleus tractus solitarius play a role in the termination of inspiration. Society for Neuroscience Abstracts 23(1-2): 725

Williams, J.A.; Colon, R.J.; Weiss, H.R. 1997: N-methyl-D-aspartate receptors control local oxygen consumption and cerebral blood flow in hypoxic newborn pigs. FASEB Journal 11(3): A484

Flynn, K.M.; Alter, E.Y.; Banerjee, S.P.; Schreibman, M.P. 1994: N-methyl-D-aspartate receptors in the brain of Xiphophorus. American Zoologist 34(5): 19A

Phul, R.K.; Smith, M.E. 1996: N-methyl-D-aspartate receptors in the cervical spinal cord in normal and dystrophic C57BL/6J mice in vitro. Journal of Physiology (Cambridge) 491P: 149P-150P

Dennis, T.; Beauchemin, V.; Lavoie, N. 1994: N-methyl-D-aspartate receptors in the rat brain following olfactory bulbectomy Autoradiographic and behavioral studies. Society for Neuroscience Abstracts 20(1-2): 934

Phul, R.K.; Smith, M.E. 1997: N-methyl-D-aspartate receptors in the ventral horn in C57BL/6J normal and dystrophic mice in vitro. Journal of Physiology (Cambridge) 504P: 213P

Young, D.; Nicholson, L.; Dragunow, M. 1994: N-methyl-D-aspartate receptors may be involved in generating electrically-induced status epilepticus. Society for Neuroscience Abstracts 20(1-2): 398

Gozal, D.; Nowak, R.D.; Gozal, Y.M.; Torres, J.E.; Nuckton, T.J.; Graff, G.R. 1996: N-methyl-D-aspartate receptors mediate afferent peripheral chemoreceptor response in the conscious rat. Journal of Investigative Medicine 44(1): 78A

Komuro, H.; Rakic, P. 1992: N-methyl-D-aspartate receptors modulate neuronal migration A laser microscopic study in a cerebellar slice preparation. Society for Neuroscience Abstracts 18(1-2): 1283

Flynn, K.M.; Schreibman, M.P.; Magliulo Cepriano, L.; Banerjee, D.P.; Yablonsky Alter, E. 1995: N-methyl-D-aspartate receptors on gonadotropin releasing hormone neurons. Society for Neuroscience Abstracts 21(1-3): 348

Flynn, K.M.; Schreibman, M.P.; Magliulo Cepriano, L. 1995: N-methyl-D-aspartate receptors on gonadotropin releasing hormone neurons in two species of Xiphophorus. American Zoologist 35(5): 22A

Karadeniz, S.; Tekeli, F.; Bilgic, L.; Guvener, B.; Kucuk, M.; Koyuncuoglu, H. 1998: N-methyl-D-aspartate receptors participate in the retinal damage due to the hypoglycaemia. Diabetologia 41(Suppl 1): A280

Pallotta, M.; Segieth, J.; Whitton, P.S. 1996: N-methyl-D-aspartate receptors regulate 5-HT release in the raphe nuclei and terminal 5-HT release in frontal cortex. British Journal of Pharmacology 119(Proceedings Suppl ): 182P

Fink, K.; Boeing, C.; Schmitz, V.; Goethert, M. 1993: N-methyl-D-aspartate stimulates serotonin and alpha-amino-butyric acid release in the rat and guinea-pig brain cortex. Fundamental and Clinical Pharmacology 7(7): 357

Ono, T.; Ogura, A.; Kudo, Y.; Ikawa, Y. 1993: N-methyl-D-aspartate suppresses apoptosis in cerebellar granule cell and promotes its survival. Neuroscience Research Suppl 1993(18): S135

Said, S.J.; Pakbaz, H.; Berisha, H.I. 1995: N-methyl-D-aspartate- and oxidant-induced lung injury Critical role of poly polymerase. Society for Neuroscience Abstracts 21(1-3): 1028

Youn, D.-H. 2008: N-methyl-D-aspartate-dependent long-term potentiation of excitatory transmission in trigeminal subnucleus oralis. Neuroreport 19(7): 733-738

Kumamoto, E.; Murata, Y. 1993: N-methyl-D-aspartate-induced currents in rat cultured septal neurones. Neuroscience Research Suppl 1993(18): S43

Delaney, S.M.; Geiger, J.D. 1995: N-methyl-D-aspartate-induced increased levels of endogenous adenosine are enhanced by inhibition of adenosine deaminase and adenosine transport in rat striatum. Society for Neuroscience Abstracts 21(1-3): 1374

Damschroder Williams, P.; Paul, S.M. 1993: N-methyl-D-aspartate-induced neuroprotection in cerebellar granule cells Evidence for a developmentally-expressed neuroprotective protein. Society for Neuroscience Abstracts 19(1-3): 1349

Black, M.A.; Tremblay, R.; Mealing, G.A.R.; Ray, R.; Durkin, J.P.; Whitfield, J.F.; Blosser, J.; Morley, P. 1995: N-methyl-D-aspartate-mediated toxicity in cultured rat cortical neurons is antagonized by FPL 15896AR. Society for Neuroscience Abstracts 21(1-3): 1343

Fitzgerald, B.P. 1994: N-methyl-D-aspartic Acid administration to mares Differential gonadotropin release in steroid-treated long-term ovariectomized mares during the breeding season and effects of ovarian status during seasonal anestrus. Biology of Reproduction 50(Suppl 1): 110

Iglesias, G.M.; Moya, A.; Rabunal, R.; Lima, L. 1996: N-methyl-D-aspartic acid and nitric oxide modulate growth hormone secretion in rats. Journal of Physiology (Cambridge) 493P: 41S

Holmgaard, K.; Aalkjaer, C.; Lambert, J.D.C.; Bek, T. 2008: N-methyl-D-aspartic acid causes relaxation of porcine retinal arterioles through an adenosine receptor-dependent mechanism. IOVS Investigative Ophthalmology and Visual Science 49(10): 4590-4594

Sheehan, T.; Paul, M.; Cirrito, J.; Numan, M. 1998: N-methyl-D-aspartic acid lesions of the medial amygdala facilitate maternal behavior in female rats hysterectomized and ovariectomized on day 12 of pregnancy. Society for Neuroscience Abstracts 24(1-2): 953